[go: up one dir, main page]

WO2020066895A1 - Skin cosmetic composition - Google Patents

Skin cosmetic composition Download PDF

Info

Publication number
WO2020066895A1
WO2020066895A1 PCT/JP2019/036973 JP2019036973W WO2020066895A1 WO 2020066895 A1 WO2020066895 A1 WO 2020066895A1 JP 2019036973 W JP2019036973 W JP 2019036973W WO 2020066895 A1 WO2020066895 A1 WO 2020066895A1
Authority
WO
WIPO (PCT)
Prior art keywords
component
mass
cosmetic composition
oil
skin cosmetic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/JP2019/036973
Other languages
French (fr)
Japanese (ja)
Inventor
松尾真樹
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Mandom Corp
Original Assignee
Mandom Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mandom Corp filed Critical Mandom Corp
Priority to JP2020549123A priority Critical patent/JP6982697B2/en
Priority to CN201980043706.7A priority patent/CN112351768A/en
Priority to KR1020207037364A priority patent/KR102532929B1/en
Publication of WO2020066895A1 publication Critical patent/WO2020066895A1/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/34Alcohols
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/34Alcohols
    • A61K8/345Alcohols containing more than one hydroxy group
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/36Carboxylic acids; Salts or anhydrides thereof
    • A61K8/361Carboxylic acids having more than seven carbon atoms in an unbroken chain; Salts or anhydrides thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/39Derivatives containing from 2 to 10 oxyalkylene groups
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/55Phosphorus compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/63Steroids; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/84Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions otherwise than those involving only carbon-carbon unsaturated bonds
    • A61K8/86Polyethers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/92Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/20Chemical, physico-chemical or functional or structural properties of the composition as a whole
    • A61K2800/26Optical properties
    • A61K2800/262Transparent; Translucent

Definitions

  • the present invention relates to a composition for skin cosmetics. More specifically, the present invention relates to an aqueous skin cosmetic composition containing an oil component.
  • Liposomes have a size on the order of 100 nm, are larger than micelles, and can contain more oil in the liposome membrane.
  • the transparency is reduced depending on the particle size of the liposome, and particularly when it is blended in a low-viscosity lotion formulation, the storage stability is poor.
  • an object of the present invention is to provide a skin cosmetic composition which can contain a relatively large amount of oil and is excellent in transparency and storage stability.
  • the present inventors have conducted intensive studies to achieve the above object, and as a result, have found that phospholipids, a specific polyoxyethylene sterol ether and / or a specific polyoxyethylene stanol ether, a specific aliphatic alcohol, and a specific polyoxyethylene sterol ether.
  • the present invention comprises the following component A, the following component B, the following component C, the following component D, the following component E, the following component F, the following component G, and the following component H,
  • a skin cosmetic composition having a mass ratio (B / A) of the component B to the component A of 5.5 to 18.0.
  • Component A Phospholipid Component B: Polyoxyethylene sterol ether having an average addition mole number of oxyethylene of 15 to 50 and / or polyoxyethylene stanol ether having an average addition mole number of oxyethylene of 15 to 50
  • Component C Branched chain Component D: one or more polyhydric alcohols selected from the group consisting of propylene glycol, dipropylene glycol, and 1,3-butylene glycol
  • Component E water
  • Component F Sterol Component
  • G Oil Component H: Polyoxyethylene hydrogenated castor oil having an average added mole number of oxyethylene of 5 to 30
  • composition for skin cosmetics preferably further contains the following component I: Component I: glycerin mono-2-ethylhexyl ether
  • composition for skin cosmetics preferably further contains the following component J.
  • Component J 1,2-alkanediol having 5 to 10 carbon atoms
  • the skin cosmetic composition of the present invention it is possible to provide a skin cosmetic composition which can contain a relatively large amount of oil and is excellent in transparency and storage stability.
  • composition for skin cosmetics of the present invention comprises a phospholipid; polyoxyethylene sterol ether having an average addition mole number of oxyethylene of 15 to 50 and / or polyoxyethylene stanol having an average addition mole number of oxyethylene of 15 to 50.
  • Ether a monovalent aliphatic alcohol having 12 to 24 carbon atoms having a branched chain; at least one polyhydric alcohol selected from the group consisting of propylene glycol, dipropylene glycol and 1,3-butylene glycol; water; sterol; Oil component containing at least polyoxyethylene hydrogenated castor oil having an average addition mole number of oxyethylene of 5 to 30.
  • the phospholipid is referred to as “Component A”, the polyoxyethylene sterol ether having an average addition mole number of oxyethylene of 15 to 50 and / or the polyoxyethylene oxyethylene having an average addition mole number of oxyethylene of 15 to 50.
  • the stanol ether is selected from the group consisting of "Component B”, and the branched chain monovalent aliphatic alcohol having 12 to 24 carbon atoms is selected from the group consisting of "Component C”, propylene glycol, dipropylene glycol and 1,3-butylene glycol.
  • One or more polyhydric alcohols are “Component D”
  • water is “Component E”
  • sterol is “Component F”
  • oil is “Component G”
  • polyoxyethylene cured castor having an average added mole number of oxyethylene of 5 to 30 is used.
  • the oils are sometimes referred to as “Component H” respectively.
  • the skin cosmetic composition of the present invention preferably further contains glycerin mono-2-ethylhexyl ether.
  • the composition for skin cosmetics of the present invention preferably further contains a 1,2-alkanediol having 5 to 10 carbon atoms.
  • the glycerin mono-2-ethylhexyl ether may be referred to as “component I” in some cases.
  • the 1,2-alkanediol having 5 to 10 carbon atoms may be referred to as “component J” in some cases.
  • the composition for skin cosmetics of the present invention contains at least component A, component B, component C, component D, component E, component F, component G, and component H.
  • the skin cosmetic composition of the present invention may further contain component I and / or component J.
  • the composition for skin cosmetics of the present invention may contain components other than the above components A to J.
  • each component contained in the skin cosmetic composition of the present invention for example, component A, component B, component C, component D, component E, component F, component G, component H, component I, component J, and Each component such as other components may be used alone or in combination of two or more.
  • Component A is a "phospholipid". Component A forms a bicellular structure (a disk-shaped lipid bilayer composed of phospholipids), which is a form of micelle. Therefore, a relatively large amount of oil can be included in the bicell structure.
  • Component A is a complex lipid containing a phosphate residue, such as a natural phospholipid, a synthetic phospholipid, or a hydrogenated phospholipid in which the unsaturated carbon chain of a naturally occurring phospholipid is saturated with hydrogen.
  • the phospholipid include natural phospholipids such as phosphatidylcholine, phosphatidylethanolamine, phosphatidylserine, phosphatidylinositol, lysophosphatidylcholine, sphingomyelin, egg yolk lecithin, soybean lecithin; Synthetic phospholipids such as stearoyl phosphatidylcholine, dioleoyl phosphatidylcholine, palmitoyl oleoyl phosphatidylcholine; hydrogenated phospholipids such as hydrogenated soybean lecithin, hydrogenated egg yolk lecithin, hydrogenated phosphatidylcholine, hydrogenated phosphatidylser
  • a commercially available product can be used.
  • Commercial products of hydrogenated soybean lecithin include, for example, trade name "COATSOME @ NC-21", trade name "COATSOME @ NC-61" (both manufactured by NOF Corporation), trade name "NIKKOL @ resinol S-10EX", trade name
  • the trade name is "NIKKOL @ Resinol S-10E", the trade name "NIKKOL @ Resinol S-10M” (above, manufactured by Nikko Chemicals Co., Ltd.), and the trade name is "Basis @ LS-60HR” (manufactured by Nisshin Oillio Group Co., Ltd.).
  • the content ratio of the component A in the skin cosmetic composition of the present invention is not particularly limited, but is preferably 0.005% by mass or more based on 100% by mass of the total amount of the skin cosmetic composition of the present invention. It is more preferably at least 0.1% by mass, further preferably at least 0.2% by mass. When the content is 0.005% by mass or more, a bicell structure is formed, the component F is stably dispersed, and the storage stability is further improved.
  • the upper limit of the content is preferably 3.0% by mass or less, more preferably 2.0% by mass or less, and even more preferably 1.5% by mass or less. When the content is 3.0% by mass or less, an excessive increase in viscosity can be suppressed, and the dispersibility can be further improved.
  • the content ratio of the component A is the sum of the content ratios of all the components A in the skin cosmetic composition of the present invention.
  • Component B is "polyoxyethylene sterol ether having an average addition mole number of oxyethylene of 15 to 50 and / or polyoxyethylene stanol ether having an average addition mole number of oxyethylene of 15 to 50". That is, the component B is one or both of the polyoxyethylene sterol ether and the polyoxyethylene stanol ether. Component B has a high affinity for component A and forms a bilayer with component A. Further, it is presumed that the curvature of the bilayer film is adjusted, thereby contributing to stabilization of the bicell structure. As component B, polyoxyethylene stanol ether is more preferred from the viewpoint of excellent oxidation stability.
  • the polyoxyethylene sterol ether or polyoxyethylene stanol ether is obtained by adding oxyethylene to sterol or stanol.
  • the average number of moles of oxyethylene to be added to sterol or stanol is 15 to 50, preferably 20 to 30.
  • Component B includes, for example, polyoxyethylene phytosterol ether, polyoxyethylene phytostanol ether, polyoxyethylene cholesterol ether, polyoxyethylene cholestanol ether and the like. Among them, vegetable polyoxyethylene phytosterol ether and polyoxyethylene phytostanol ether are preferred. As the component B, only one type may be used, or two or more types may be used.
  • ком ⁇ онент B a commercially available product may be used.
  • Examples of commercially available products of Component B include “NIKKOL @ BPS-20”, trade name “NIKKOL @ BPS-30”, and trade name “NIKKOL @ BPSH-25” (all manufactured by Nikko Chemicals Co., Ltd.).
  • the content ratio of the component B in the skin cosmetic composition of the present invention is not particularly limited, but is preferably 0.03% by mass or more based on 100% by mass of the total amount of the skin cosmetic composition of the present invention, It is more preferably at least 1.0% by mass. When the content is 0.03% by mass or more, it sufficiently contributes to stabilization of the bicell structure, and is further excellent in transparency and storage stability.
  • the upper limit of the content ratio is preferably 15.0% by mass or less, and more preferably 10.0% by mass or less. When the content ratio is 15.0% by mass or less, an excessive increase in viscosity can be suppressed, and the dispersibility can be further improved.
  • the content ratio of the component B is the sum of the content ratios of all the component B in the skin cosmetic composition of the present invention.
  • the mass ratio (B / A) of the component B to the component A in the skin cosmetic composition of the present invention is 5.5 or more, preferably 6.0 or more, more preferably 7.0 or more. Further, the mass ratio (B / A) is 18.0 or less, preferably 15.0 or less, more preferably 12.0 or less. When the mass ratio (B / A) is within the above range, transparency and storage stability are more excellent.
  • Component C is “a monovalent aliphatic alcohol having a branched chain and having 12 to 24 carbon atoms”. It is presumed that the use of Component C softens the lipid bilayer membrane and contributes to stabilization.
  • Component C includes, for example, octyldodecanol, decyltetradecanol, isostearyl alcohol and the like. Among them, octyldodecanol and decyltetradecanol are preferred from the viewpoint of improving storage stability. As the component C, only one type may be used, or two or more types may be used.
  • the content ratio of the component C in the skin cosmetic composition of the present invention is not particularly limited, but is preferably 0.005% by mass or more based on 100% by mass of the total amount of the skin cosmetic composition of the present invention. It is more preferably at least 0.05% by mass, and even more preferably at least 0.1% by mass. When the content is 0.005% by mass or more, the storage stability is further improved.
  • the upper limit of the content ratio is preferably 0.5% by mass or less, more preferably 0.4% by mass or less. When the content is 0.5% by mass or less, the transparency is further improved.
  • the content ratio of the component C is the sum of the content ratios of all the components C in the skin cosmetic composition of the present invention.
  • the mass ratio (C / A) of the component C to the component A in the skin cosmetic composition of the present invention is not particularly limited, but is preferably 0.05 or more, more preferably 0.1 or more, and still more preferably. 0.15 or more. When the mass ratio (C / A) is 0.05 or more, the storage stability is further improved.
  • the upper limit of the mass ratio (C / A) is preferably 1.0 or less, more preferably 0.7 or less, and even more preferably 0.5 or less. When the mass ratio (C / A) is 1.0 or less, transparency is further improved.
  • Component D is "one or more polyhydric alcohols selected from the group consisting of propylene glycol, dipropylene glycol and 1,3-butylene glycol".
  • Component D functions as a solvent for other components during production of the skin cosmetic composition.
  • an increase in the viscosity of the dispersion when other components are dispersed is suppressed, and the dispersibility is improved.
  • the component D only one type may be used, or two or more types may be used.
  • the content ratio of the component D in the skin cosmetic composition of the present invention is not particularly limited, but is preferably 0.25% by mass or more based on 100% by mass of the total amount of the skin cosmetic composition of the present invention. It is more preferably at least 3.0% by mass, and even more preferably at least 5.0% by mass.
  • the upper limit of the content is preferably 30.0% by mass or less, more preferably 25.0% by mass or less, and still more preferably 15.0% by mass or less. When the content is in the above range, transparency and storage stability are further improved.
  • the content ratio of the component D is the sum of the content ratios of all the components D in the skin cosmetic composition of the present invention.
  • the mass ratio (D / A) of the component D to the component A in the skin cosmetic composition of the present invention is not particularly limited, but is preferably 8.0 or more, more preferably 10.0 or more.
  • the upper limit of the mass ratio (D / A) is preferably 60.0 or less, more preferably 30.0 or less, and even more preferably 20.0 or less. When the mass ratio (D / A) is within the above range, the composition for skin cosmetics is more excellent in preventing cloudiness.
  • Component E is "water”. By using water, freshness and freshness can be imparted to the skin cosmetic composition of the present invention, and further the skin cosmetic composition of the present invention is applied to skin cosmetics such as aqueous lotions. be able to.
  • the content ratio of the component E in the skin cosmetic composition of the present invention is not particularly limited, but is preferably 55.0% by mass or more based on 100% by mass of the total amount of the skin cosmetic composition of the present invention. It is more preferably at least 60.0% by mass, still more preferably at least 65.0% by mass. The content is preferably 95.0% by mass or less, more preferably 90.0% by mass or less, and still more preferably 85.0% by mass or less. It is preferable that the compounding ratio be within the above range, since simplicity and a refreshing feeling upon application to an aqueous lotion can be obtained.
  • Component F is a "sterol”. Component F is presumed to adjust the curvature of the bilayer and thereby contribute to the stabilization of the bicell structure. In addition, it is also blended as an active ingredient for improving skin barrier function and the like.
  • the component F includes, for example, animal sterol, plant sterol (phytosterol) and the like.
  • Animal sterols include, for example, cholesterol, cholestanol, 7-dehydrocholesterol and the like.
  • Examples of the plant sterol include sitosterol, stigmasterol, fucosterol, spinasterol, and brassicasterol.
  • As the component F only one type may be used, or two or more types may be used.
  • component F a commercially available product can be used.
  • examples of commercial products of Component F include, for example, trade name “Cholesterol JSQI”, trade name “Cholesterol of Japanese Pharmacopoeia” (all manufactured by Nippon Seika Co., Ltd.), and trade name “phytosterol” (manufactured by Eisai Food Chemical Co., Ltd.) And the trade name "Phytosterol-SKP” (manufactured by Tama Seikagaku Co., Ltd.).
  • the content ratio of the component F in the skin cosmetic composition of the present invention is not particularly limited, but is preferably 0.01% by mass or more based on 100% by mass of the total amount of the skin cosmetic composition of the present invention, It is more preferably at least 0.1% by mass, further preferably at least 0.2% by mass. When the content is 0.01% by mass or more, a barrier function or the like can be imparted to the skin.
  • the upper limit of the content is preferably 2.0% by mass or less, more preferably 1.0% by mass or less, and even more preferably 0.6% by mass or less. When the mass ratio is 2.0% by mass or less, the storage stability is further improved.
  • the content ratio of the component F is the sum of the content ratios of all the components F in the skin cosmetic composition of the present invention.
  • Component G is “oil”.
  • Component G includes, for example, vegetable oil, ester oil, silicone oil, hydrocarbon oil, wax, higher fatty acid, higher alcohol other than component C, and the like.
  • Component G is used as an emollient component in the skin cosmetic composition of the present invention, for example, to prevent evaporation of skin moisture and to soften keratin.
  • the component G does not include the component F.
  • As the component G only one type may be used, or two or more types may be used.
  • Examples of the vegetable oil include macadamia nut oil, eucalyptus oil, coconut oil, avocado oil, safflower oil, olive oil, palm oil, palm kernel oil, kukui nut oil, shea butter (shea butter), cocoa butter, almond oil, and sunflower oil.
  • Rose hip oil olive squalane, camelia oil, kiwi fruit seed oil, camellia oil, apricot kernel oil, sesame oil, soybean oil, jojoba oil, castor oil, hazelnut oil, meadowfoam oil, peppermint oil, argan oil, carrot oil, lavender Oil, sugar squalane, damask rose flower wax, centifolia rose flower wax, scotch flower wax, camellia oil, hydrogenated products thereof (for example, hydrogenated castor oil, hydrogenated jojoba oil, hydrogenated palm oil, hydrogenated avocado oil, Hydrogenated soybean oil and the like).
  • ester oil examples include ethyl oleate, isopropyl myristate, isopropyl palmitate, myristyl myristate, cetyl palmitate, 2-ethylhexyl palmitate, octyl dodecyl myristate, isopropyl isostearate, propylene glycol isostearate, and propylene glycol isostearate.
  • silicone oil examples include, but are not particularly limited to, dimethyl silicone oil such as methylpolysiloxane and highly polymerized methylpolysiloxane; methylphenyl silicone oil such as methylphenylpolysiloxane; methylcyclopolysiloxane, octamethylcyclotetrasiloxane; Cyclic silicone oils such as decamethylcyclopentasiloxane and dodecamethylcyclohexasiloxane; aminopropylmethylsiloxane / dimethylsiloxane copolymer, aminoethylaminopropylsiloxane / dimethylsiloxane copolymer, aminoethylaminopropylmethylsiloxane / dimethylsiloxane Amino-modified silicone, carboxy-modified silicone, fatty acid-modified silicone, alcohol-modified silicone, aliphatic alcohol-modified silicone such as polymers Emissions, epoxy-
  • hydrocarbon oil examples include ⁇ -olefin oligomer, petrolatum, isoparaffin, light isoparaffin, light liquid isoparaffin, squalane, synthetic squalane, vegetable squalane, liquid isoparaffin, liquid paraffin, hydrogenated polyisobutene, hydrogenated (tetradecenyl / Methylpentadecene), isododecane and the like.
  • wax examples include carnauba wax, candelilla wax, beeswax, rice bran wax, shellac wax, whale wax, lanolin, sunflower seed wax and the like.
  • higher fatty acids examples include lauric acid, myristic acid, palmitic acid, stearic acid, isostearic acid, and oleic acid.
  • Examples of higher alcohols other than the above-mentioned component C include cetyl alcohol, stearyl alcohol, myristyl alcohol, oleyl alcohol and the like.
  • component G preferably contains a highly polar oil component. Further, the highly polar oil component more preferably has a sterol skeleton. When a highly polar oil component is contained as the component G, the emollient effect is further improved. As the highly polar oil, only one kind may be used, or two or more kinds may be used.
  • any of plant-derived, animal-derived, and mineral-derived oils can be used.
  • polar fats and oils include hydrogenated palm oil, hydrogenated jojoba oil, shea butter, (adipic acid / 2-ethylhexanoic acid / stearic acid) glyceryl oligoester, macadamia nut oil fatty acid phytosteryl, glyceryl tricaprylate, glyceryl tricaprate, Glyceryl trimyristate, glyceryl tristearate, phytosteryl oleate, dipentaerythrityl hydroxystearate, dipentaerythrityl stearate, dipentaerythrityl rosinate, dipentaerythrityl hexahydroxystearate, and the like.
  • Phytosteryl oleate is preferred from the viewpoint of further enhancing the emollient effect of the skin cosmetic composition of the present invention.
  • the content ratio of the component G in the skin cosmetic composition of the present invention is not particularly limited, but is preferably 0.01% by mass or more based on 100% by mass of the total amount of the skin cosmetic composition of the present invention. More preferably, it is 0.05% by mass or more. When the content is 0.01% by mass or more, emollient effects such as moisturizing and keratin softening are further exhibited.
  • the content is preferably 0.3% by mass or less, more preferably 0.2% by mass or less. When the content is 0.3% by mass or less, the storage stability is further improved.
  • the content ratio of the component G is the sum of the content ratios of all the components G in the skin cosmetic composition of the present invention.
  • the mass ratio (G / A) of the component G to the component A in the skin cosmetic composition of the present invention is not particularly limited, but is preferably 0.01 or more, more preferably 0.02, and still more preferably. Is 0.05 or more.
  • the mass ratio (G / A) is preferably 1.0 or less, more preferably 0.8 or less, and even more preferably 0.5 or less. When the mass ratio (G / A) is within the above range, the storage stability is more excellent.
  • Component H is "polyoxyethylene hydrogenated castor oil having an average addition mole number of oxyethylene of 5 to 30". Component H is presumed to adjust the curvature of the bilayer in the skin cosmetic composition of the present invention, thereby contributing to stabilization of the bicell structure. In particular, it exerts an effect of stably confining the component G in the film and improving storage stability. As the component H, only one type may be used, or two or more types may be used.
  • the average number of moles of oxyethylene added as the component H is 5 to 30.
  • the average number of moles added is preferably 10 or more, more preferably 15 or more, and preferably 25 or less.
  • the oil component is more stably confined in the bicell, and the effect of increasing the storage stability is further exhibited.
  • the component H is most preferably a polyoxyethylene hydrogenated castor oil having an average addition number of oxyethylene of 20.
  • the HLB (Hydrophil-Lipophile Balance) value of the component H is not particularly limited, but is, for example, 6.0 to 11.0, and preferably 6.5 to 10.5.
  • Use of the component H having an HLB value in the above range contributes to storage stability. The more the HLB value of the component H indicates lipophilicity, the better the storage stability. Note that the HLB value can be calculated by the Griffin method.
  • the content ratio of the component H in the skin cosmetic composition of the present invention is not particularly limited, but is preferably 0.05% by mass or more based on 100% by mass of the total amount of the skin cosmetic composition of the present invention. It is more preferably at least 0.5% by mass.
  • the content is preferably 5.0% by mass or less, more preferably 3.0% by mass or less, and further preferably 2.0% by mass or less. When the content is within the above range, the effect of stably confining the component G in the lipid bilayer membrane is more excellent.
  • the content ratio of the component H is the sum of the content ratios of all the component Hs in the skin cosmetic composition of the present invention.
  • Component I is "glycerin mono 2-ethylhexyl ether” (also referred to as “octoxyglycerin”). When component I is contained, it is presumed that flexibility is imparted to the membrane shape because it penetrates into the bicellular lipid bilayer membrane. For this reason, the composition for skin cosmetics of the present invention further improves transparency and storage stability.
  • the content ratio of Component I in the skin cosmetic composition of the present invention is not particularly limited.
  • the amount is preferably 0.01% by mass or more, more preferably 0.05% by mass or more, and still more preferably 0.1% by mass or more, based on the total amount of 100% by mass.
  • the upper limit of the content ratio is preferably 2.0% by mass or less, more preferably 1.5% by mass or less, and further preferably 1.0% by mass or less. (4) When the content is 2.0% by mass or less, a less irritating agent can be obtained.
  • Component J is "1,2-alkanediol having 5 to 10 carbon atoms".
  • component J is contained, it is presumed that flexibility is imparted to the membrane shape because it enters the bilayer lipid bilayer membrane. For this reason, the composition for skin cosmetics of the present invention further improves transparency and storage stability.
  • component J for example, 1,2-pentanediol, 1,2-hexanediol, 1,2-octanediol, 1,2-decanediol and the like can be mentioned.
  • component J only one type may be used, or two or more types may be used.
  • the content ratio of the component J in the skin cosmetic composition of the present invention is not particularly limited.
  • the amount is preferably 0.01% by mass or more, more preferably 0.1% by mass or more, and still more preferably 0.2% by mass or more based on the total amount of 100% by mass.
  • the upper limit of the content is preferably 2.0% by mass or less, more preferably 1.0% by mass or less, and even more preferably 0.7% by mass or less.
  • the content ratio of the component J is the sum of the content ratios of all the components J in the skin cosmetic composition of the present invention.
  • the skin cosmetic composition of the present invention may further contain other components other than the above components A to J.
  • the other components are not particularly limited, but include, for example, surfactants other than component H (cationic surfactant, anionic surfactant, nonionic surfactant, amphoteric surfactant, etc.), lower alcohols, other than component C Higher alcohols, polyhydric alcohols other than component D, ultraviolet absorbers, powders, antioxidants, preservatives, fragrances, coloring agents, chelating agents, cooling agents, thickeners, vitamins, neutralizing agents, amino acids, Additives such as pH adjusters, whitening agents, anti-inflammatory agents, deodorants, plant and animal extracts, sequestering agents, and the like. As the other components, only one kind may be used, or two or more kinds may be used.
  • the skin cosmetic composition of the present invention preferably has a transparent appearance from the viewpoint of aesthetics. Further, the high transparency of the composition for skin cosmetics of the present invention means that the incorporated oil does not agglomerate or cream, and indicates that the composition is in a very stable state. For this reason, the transparency of the skin cosmetic composition of the present invention also serves as an index of storage stability.
  • component A forms a bicellular structure which is a form of micelle.
  • the bicell structure is a disk-shaped lipid bilayer composed of phospholipids.
  • the bicellular structure in the skin cosmetic composition of the present invention has a particle size of about 20 to 50 nm, which is between micelles and liposomes.
  • an oil component can be compounded in the lipid bilayer membrane, a larger amount of oil component can be compounded than a micelle.
  • it since it does not have the particle size of liposomes, it has excellent storage stability. Further, with the bicell structure, transparency is not impaired.
  • the skin cosmetic composition of the present invention is preferably a skin cosmetic composition that does not contain liposomes formed from phospholipids.
  • the pH of the skin cosmetic composition of the present invention is not particularly limited, but is preferably, for example, 5.0 to 8.0 at 25 ° C.
  • the viscosity of the composition for skin cosmetics of the present invention is not particularly limited.
  • the viscosity at 25 ° C. is preferably 0.5 to 1000 mPa ⁇ s, and more preferably 0.5 to 500 mPa ⁇ s. More preferred.
  • the viscosity is measured at a rotational speed of 60 r / min by using a B-type viscometer, selecting a rotor suitable for the viscosity.
  • the average particle size of the bicell structure of the skin cosmetic composition of the present invention is not particularly limited, but is preferably 20 nm or more, more preferably 30 nm or more, and further preferably 40 nm or more.
  • the upper limit of the average particle diameter is preferably 100 nm or less, more preferably 90 nm or less, and still more preferably 80 nm or less.
  • the upper limit of the average particle diameter is 100 nm or less, the storage stability and the transparency are more excellent.
  • the above average particle diameter (nm) can be measured using a dynamic light scattering photometer or a transmission electron microscope (TEM).
  • the composition can be produced by mixing the above-mentioned components and stirring with a known method, for example, using a homomixer.
  • the composition for skin cosmetics of the present invention can be used as a raw material (so-called intermediate raw material) used in the production of skin cosmetics.
  • the composition for skin cosmetics of the present invention can be stably dispersed in an aqueous or low-viscosity dispersion medium, so that the component G can be incorporated into the skin cosmetics.
  • the composition for skin cosmetics of the present invention can be used as a skin cosmetic as such.
  • a skin cosmetic containing the above-described composition for skin cosmetic of the present invention is obtained.
  • skin cosmetic containing the composition for skin cosmetics of the present invention may be referred to as “skin cosmetic of the present invention”.
  • the content of the skin cosmetic composition of the present invention in 100% by mass of the skin cosmetic of the present invention is not particularly limited, but is preferably 0.1 to 100% by mass, more preferably 0.5 to 10.0%. % By mass.
  • the dosage form of the composition for skin cosmetics (or skin cosmetics) of the present invention is not particularly limited, and examples thereof include lotions (creams), gels, emulsions, aerosol sprays, natural sprays, sticks, powders, and the like.
  • Various dosage forms such as roll-on, sheet (paper) and the like can be mentioned.
  • lotions (lotions), creams, gels and emulsions are preferable, and lotions (lotions) are more preferable.
  • the skin cosmetic composition (or skin cosmetic) of the present invention are not particularly limited, and include, for example, moisturizing cosmetics, whitening cosmetics, acne care cosmetics, and anti-aging cosmetics (eg, wrinkle suppression, sagging suppression) Skin care cosmetics (for the purpose of, etc.); scalp care cosmetics (for the purpose of moisturizing, suppressing sebum, etc.); deodorant cosmetics; sunscreen cosmetics; shaving cosmetics; Body shampoo, bar soap, etc.)
  • the skin cosmetic composition (or skin cosmetic) of the present invention is preferably a skin care cosmetic or a scalp care cosmetic, and more preferably a skin care cosmetic.
  • the skin cosmetic composition (or skin cosmetic) of the present invention may be, for example, any of cosmetics, quasi-drugs, pharmaceuticals, and miscellaneous goods.
  • the site to which the skin cosmetic composition (or skin cosmetic) of the present invention is applied is not particularly limited, and may include a face (for example, forehead, eyes, eyes, cheeks, mouth, etc.), arm, elbow, back of hand, fingertip. , Feet, knees, heels, neck, sides, back, scalp and the like.
  • the composition for skin cosmetics of the present invention is a skin cosmetic composition containing water (component E) as a medium, wherein the average addition mole number of phospholipid (component A) and oxyethylene is 15 to 50.
  • Polyoxyethylene stanol ether having an average addition mole number of ether and / or oxyethylene of 15 to 50 (component B), a monovalent aliphatic alcohol having a branched chain having 12 to 24 carbon atoms (component C), propylene glycol,
  • One or more polyhydric alcohols selected from the group consisting of dipropylene glycol and 1,3-butylene glycol (component D), sterols (component F), oils (component G), and an average number of moles of added oxyethylene of 5 to 5 Contains 30 polyoxyethylene hydrogenated castor oil (Component H).
  • the bicellular structure in the skin cosmetic composition of the present invention is composed of component B, component C, component F, component G, and component H, with component A as the center.
  • Component D functions as a solvent for other components during production.
  • component B, component F, and component H adjust the curvature of the lipid bilayer
  • component C contributes to the flexibility of the lipid bilayer.
  • stability of the bicell structure is particularly improved.
  • blending of component G tends to destabilize the bicell structure, but in the present invention, in particular, by including component H as a component of the lipid bilayer, the bicomponent structure can be contained in the lipid bilayer.
  • the feature is that G can be stably compounded.
  • the bicellular structure in the skin cosmetic composition of the present invention has a particle size of about 20 to 50 nm, which is between micelles and liposomes.
  • the component G can be compounded in the lipid bilayer membrane, more components G can be compounded than the micelle.
  • it since it does not have the particle size of liposomes, it has excellent storage stability. Further, if the particle size is within the above range, transparency is not impaired.
  • the skin cosmetic composition of the present invention can be excellent in transparency and storage stability while being an aqueous skin cosmetic composition containing an oil having an emollient effect.
  • the compounding amount described in the table is the compounding amount of each component (that is, the compounding amount of the active ingredient in each raw material; so-called pure content), and is represented by "% by mass” unless otherwise specified.
  • Hydrogenated lecithin hydrogenated soybean lecithin
  • Polyoxyethylene phytostanol trade name "NIKKOL BPSH-25", manufactured by Nikko Chemicals Co., Ltd., POE-25 phytostanol polyoxyethylene phytosterol A: trade name "NIKKOL BPS-20", Nikko Chemicals Co., Ltd., POE-20 phytosterol polyoxyethylene phytosterol B: trade name "NIKKOL BPS-30", Nikko Chemicals Co., Ltd., POE-30 phytosterol polyoxyethylene phytosterol C: trade name "NIKKOL BPS-5", Nikko POE-5 phytosterol polyoxyethylene phytosterol D manufactured by Chemicals Co., Ltd .: trade name "NIKKOL BPS-10", POE-10 phyto manufactured by Nikko Chemicals Co., Ltd.
  • Sterol Sterol Phytosterol Polyoxyethylene-hardened castor oil A: Trade name "EMALEX HC-20", manufactured by Nippon Emulsion Co., Ltd., PEG-20 hydrogenated castor oil, HLB: 9.0 Polyoxyethylene hydrogenated castor oil B: trade name "Brownon RCW-40", manufactured by Aoki Yushi Kogyo KK, PEG-40 hydrogenated castor oil, HLB: 12.5 Polyoxyethylene hydrogenated castor oil C: trade name "Brownon RCW-50", manufactured by Aoki Yushi Kogyo KK, PEG-50 hydrogenated castor oil, HLB: 13.5 Polyethylene glycol monostearate: trade name "MYS-40V”, manufactured by Nikko Chemicals Co., Ltd., PEG-40 stearate
  • Comparative Example 1 which lacks any of the components A, B, F, and H, can separate, precipitate, or precipitate under any of low-temperature storage (5 ° C.) and high-temperature storage (40 ° C.).
  • Comparative Examples 1 to 3 which lack the components A, B, or F, which are the main components of the bicellular bilayer membrane, it is presumed that the bicell structure itself was not formed.
  • component H polyoxyethylene hydrogenated castor oil having a specific number of moles of oxyethylene added
  • Comparative Examples 4 to 10 lacking this did not stabilize the bicell structure and collapsed. It is supposed to be.
  • Comparative Example 11 when the B / A value was outside the range specified in the present invention, the storage stability at low and high temperatures was poor.
  • the skin cosmetic composition of the present invention it is possible to provide a skin cosmetic composition which can contain a relatively large amount of oil and is excellent in transparency and storage stability.

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Birds (AREA)
  • Emergency Medicine (AREA)
  • Dermatology (AREA)
  • Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Cosmetics (AREA)

Abstract

Provided is a skin cosmetic composition capable of including a comparatively large amount of oil and having excellent transparency and storage stability. The skin cosmetic composition contains a component A, a component B, a component C, a component D, a component E, a component F, a component G, and a component H. The mass ratio (B/A) of component B to component A is 5.5–18.0. Component A is a phospholipid; component B is a polyoxyethylene sterol ether having an average of 15–50 oxyethylene moles added thereto and/or a polyoxyethylene stanol ether having an average of 15–50 oxyethylene moles added thereto; component C is a C12–24 monovalent aliphatic alcohol having a branched chain; component D is at least one type of polyvalent alcohol selected from the group consisting of propylene glycol, dipropylene glycol, and 1, 3–butylene glycol; component E is water; component F is a sterol; component G is an oil; and component H is a polyoxyethylene hydrogenated castor oil having an average of 5–30 oxyethylene moles added thereto.

Description

皮膚化粧料用組成物Composition for skin cosmetics

 本発明は皮膚化粧料用組成物に関する。より詳細には、油分を含有する水系の皮膚化粧料用組成物に関する。 The present invention relates to a composition for skin cosmetics. More specifically, the present invention relates to an aqueous skin cosmetic composition containing an oil component.

 従来、肌の水分の蒸散を防ぎ、角質を柔軟にするなどエモリエント効果があり、保湿性に寄与することから、油分を水系化粧料へ配合することが試みられている。水系化粧料に、水に難溶性の油分を配合するための技術として、ミセルによる可溶化(例えば、特許文献1)や、キャリアとしてリポソーム(閉鎖小胞体)(例えば、特許文献2)を用いる技術などが知られている。 Conventionally, there is an emollient effect such as prevention of transpiration of skin moisture and softening of keratin, and it contributes to moisturizing properties. Therefore, it has been attempted to incorporate oil into water-based cosmetics. As a technique for blending an oil component that is hardly soluble in water with an aqueous cosmetic, a technique of solubilizing micelles (for example, Patent Document 1) and a technique using liposomes (closed endoplasmic reticulum) as a carrier (for example, Patent Document 2) Etc. are known.

特開平11-262653号公報Japanese Patent Application Laid-Open No. H11-262563 特開平5-286824号公報JP-A-5-286824

 しかしながら、エモリエント効果を発揮するほどの量の油分を配合した透明な水系化粧料を調製することは極めて困難であった。例えば、ノニオン界面活性剤よりミセルを形成する場合、ミセルの大きさは通常10~20nm程度と非常に小さく、ミセル内に油分を取り込むスペースが十分ではなく、配合できる油分の量は限定的となる。このため、外観が透明な水系化粧料が得られるものの、十分なエモリエント効果が得られるとは言い難い。 However, it was extremely difficult to prepare a transparent water-based cosmetic containing an amount of oil sufficient to exert an emollient effect. For example, when micelles are formed from nonionic surfactants, the size of the micelles is usually very small, typically about 10 to 20 nm, and there is not enough space to take in oils in the micelles, and the amount of oils that can be blended is limited. . For this reason, although a water-based cosmetic having a transparent appearance can be obtained, it cannot be said that a sufficient emollient effect can be obtained.

 また、リポソームによって油分を配合する技術にも問題がある。リポソームは100nmオーダーのサイズで、ミセルよりも大きく、リポソーム膜内に油分をより多く配合できる。しかし、リポソームの粒径に依存して透明性は低下し、特に、低粘度のローション剤型に配合した場合は、保存安定性に劣る。 There is also a problem with the technology of blending oil with liposomes. Liposomes have a size on the order of 100 nm, are larger than micelles, and can contain more oil in the liposome membrane. However, the transparency is reduced depending on the particle size of the liposome, and particularly when it is blended in a low-viscosity lotion formulation, the storage stability is poor.

 従って、本発明の目的は、油分を比較的多量に含むことができ、且つ透明性及び保存安定性に優れる皮膚化粧料用組成物を提供することにある。 Accordingly, an object of the present invention is to provide a skin cosmetic composition which can contain a relatively large amount of oil and is excellent in transparency and storage stability.

 本発明者は、上記目的を達成するために鋭意検討した結果、リン脂質と、特定のポリオキシエチレンステロールエーテル及び/又は特定のポリオキシエチレンスタノールエーテルと、特定の脂肪族アルコールと、特定の多価アルコールと、水と、ステロールと、油分と、特定のポリオキシエチレン硬化ヒマシ油を含有し、リン脂質と、特定のポリオキシエチレンステロールエーテル及び/又は特定のポリオキシエチレンスタノールエーテルを特定の質量比とする水系の皮膚化粧料用組成物によれば、油分を比較的多量に含むことができ、且つ透明性及び保存安定性に優れる皮膚化粧料用組成物が得られることを見出した。本発明はこれらの知見に基づいて完成させたものである。 The present inventors have conducted intensive studies to achieve the above object, and as a result, have found that phospholipids, a specific polyoxyethylene sterol ether and / or a specific polyoxyethylene stanol ether, a specific aliphatic alcohol, and a specific polyoxyethylene sterol ether. A polyhydric alcohol, water, a sterol, an oil component, a specific polyoxyethylene hydrogenated castor oil, and a phospholipid, a specific polyoxyethylene sterol ether and / or a specific polyoxyethylene stanol ether having a specific mass. It has been found that according to a water-based skin cosmetic composition having a relative ratio, a skin cosmetic composition which can contain a relatively large amount of oil and has excellent transparency and storage stability can be obtained. The present invention has been completed based on these findings.

 すなわち、本発明は、下記成分Aと、下記成分Bと、下記成分Cと、下記成分Dと、下記成分Eと、下記成分Fと、下記成分Gと、下記成分Hとを含有し、上記成分Aに対する上記成分Bの質量比(B/A)が5.5~18.0である皮膚化粧料用組成物を提供する。
 成分A:リン脂質
 成分B:オキシエチレンの平均付加モル数が15~50のポリオキシエチレンステロールエーテル及び/又はオキシエチレンの平均付加モル数が15~50のポリオキシエチレンスタノールエーテル
 成分C:分岐鎖を有する炭素数12~24の1価の脂肪族アルコール
 成分D:プロピレングリコール、ジプロピレングリコール及び1,3-ブチレングリコールからなる群より選ばれた一種以上の多価アルコール
 成分E:水
 成分F:ステロール
 成分G:油分
 成分H:オキシエチレンの平均付加モル数が5~30のポリオキシエチレン硬化ヒマシ油
That is, the present invention comprises the following component A, the following component B, the following component C, the following component D, the following component E, the following component F, the following component G, and the following component H, Provided is a skin cosmetic composition having a mass ratio (B / A) of the component B to the component A of 5.5 to 18.0.
Component A: Phospholipid Component B: Polyoxyethylene sterol ether having an average addition mole number of oxyethylene of 15 to 50 and / or polyoxyethylene stanol ether having an average addition mole number of oxyethylene of 15 to 50 Component C: Branched chain Component D: one or more polyhydric alcohols selected from the group consisting of propylene glycol, dipropylene glycol, and 1,3-butylene glycol Component E: water Component F: Sterol Component G: Oil Component H: Polyoxyethylene hydrogenated castor oil having an average added mole number of oxyethylene of 5 to 30

 上記皮膚化粧料用組成物は、下記成分Iをさらに含有することが好ましい
 成分I:グリセリンモノ2-エチルヘキシルエーテル
The composition for skin cosmetics preferably further contains the following component I: Component I: glycerin mono-2-ethylhexyl ether

 上記皮膚化粧料用組成物は、下記成分Jをさらに含有することが好ましい。
 成分J:炭素数5~10の1,2-アルカンジオール
The above-mentioned composition for skin cosmetics preferably further contains the following component J.
Component J: 1,2-alkanediol having 5 to 10 carbon atoms

 本発明の皮膚化粧料用組成物によれば、油分を比較的多量に含むことができ、且つ透明性及び保存安定性に優れる皮膚化粧料用組成物を提供することができる。 According to the skin cosmetic composition of the present invention, it is possible to provide a skin cosmetic composition which can contain a relatively large amount of oil and is excellent in transparency and storage stability.

 本発明の皮膚化粧料用組成物は、リン脂質;オキシエチレンの平均付加モル数が15~50のポリオキシエチレンステロールエーテル及び/又はオキシエチレンの平均付加モル数が15~50のポリオキシエチレンスタノールエーテル;分岐鎖を有する炭素数12~24の1価の脂肪族アルコール;プロピレングリコール、ジプロピレングリコール及び1,3-ブチレングリコールからなる群より選ばれた一種以上の多価アルコール;水;ステロール;油分;オキシエチレンの平均付加モル数が5~30のポリオキシエチレン硬化ヒマシ油を少なくとも含む。なお、本明細書において、リン脂質を「成分A」、オキシエチレンの平均付加モル数が15~50のポリオキシエチレンステロールエーテル及び/又はオキシエチレンの平均付加モル数が15~50のポリオキシエチレンスタノールエーテルを「成分B」、分岐鎖を有する炭素数12~24の1価の脂肪族アルコールを「成分C」、プロピレングリコール、ジプロピレングリコール及び1,3-ブチレングリコールからなる群より選ばれた一種以上の多価アルコールを「成分D」、水を「成分E」、ステロールを「成分F」、油分を「成分G」、オキシエチレンの平均付加モル数が5~30のポリオキシエチレン硬化ヒマシ油を「成分H」とそれぞれ称する場合がある。 The composition for skin cosmetics of the present invention comprises a phospholipid; polyoxyethylene sterol ether having an average addition mole number of oxyethylene of 15 to 50 and / or polyoxyethylene stanol having an average addition mole number of oxyethylene of 15 to 50. Ether; a monovalent aliphatic alcohol having 12 to 24 carbon atoms having a branched chain; at least one polyhydric alcohol selected from the group consisting of propylene glycol, dipropylene glycol and 1,3-butylene glycol; water; sterol; Oil component containing at least polyoxyethylene hydrogenated castor oil having an average addition mole number of oxyethylene of 5 to 30. In the present specification, the phospholipid is referred to as “Component A”, the polyoxyethylene sterol ether having an average addition mole number of oxyethylene of 15 to 50 and / or the polyoxyethylene oxyethylene having an average addition mole number of oxyethylene of 15 to 50. The stanol ether is selected from the group consisting of "Component B", and the branched chain monovalent aliphatic alcohol having 12 to 24 carbon atoms is selected from the group consisting of "Component C", propylene glycol, dipropylene glycol and 1,3-butylene glycol. One or more polyhydric alcohols are "Component D", water is "Component E", sterol is "Component F", oil is "Component G", and polyoxyethylene cured castor having an average added mole number of oxyethylene of 5 to 30 is used. The oils are sometimes referred to as "Component H" respectively.

 本発明の皮膚化粧料用組成物は、さらに、グリセリンモノ2-エチルヘキシルエーテルを含むことが好ましい。また、本発明の皮膚化粧料用組成物は、さらに、炭素数5~10の1,2-アルカンジオールを含むことが好ましい。なお、本明細書において、上記グリセリンモノ2-エチルヘキシルエーテルを「成分I」と称する場合がある。また、上記炭素数5~10の1,2-アルカンジオールを「成分J」と称する場合がある。 皮膚 The skin cosmetic composition of the present invention preferably further contains glycerin mono-2-ethylhexyl ether. Further, the composition for skin cosmetics of the present invention preferably further contains a 1,2-alkanediol having 5 to 10 carbon atoms. In the present specification, the glycerin mono-2-ethylhexyl ether may be referred to as “component I” in some cases. Further, the 1,2-alkanediol having 5 to 10 carbon atoms may be referred to as “component J” in some cases.

 すなわち、本発明の皮膚化粧料用組成物は、成分A、成分B、成分C、成分D、成分E、成分F、成分G、及び成分Hを少なくとも含む。本発明の皮膚化粧料用組成物は、さらに成分I及び/又は成分Jを含んでいてもよい。また、本発明の皮膚化粧料用組成物は、上記成分A~J以外の成分を含んでいてもよい。また、本発明の皮膚化粧料用組成物に含まれる各成分、例えば、成分A、成分B、成分C、成分D、成分E、成分F、成分G、成分H、成分I、成分J、及び他の成分等の各成分は、それぞれ、一種のみを用いてもよいし、二種以上を用いてもよい。 That is, the composition for skin cosmetics of the present invention contains at least component A, component B, component C, component D, component E, component F, component G, and component H. The skin cosmetic composition of the present invention may further contain component I and / or component J. Further, the composition for skin cosmetics of the present invention may contain components other than the above components A to J. Further, each component contained in the skin cosmetic composition of the present invention, for example, component A, component B, component C, component D, component E, component F, component G, component H, component I, component J, and Each component such as other components may be used alone or in combination of two or more.

[成分A]
 成分Aは「リン脂質」である。成分Aはミセルの一形態であるバイセル構造(リン脂質で構成されたディスク状の脂質二分子膜)を形成する。このため、バイセル構造内に油分を比較的多量に包含することができる。
[Component A]
Component A is a "phospholipid". Component A forms a bicellular structure (a disk-shaped lipid bilayer composed of phospholipids), which is a form of micelle. Therefore, a relatively large amount of oil can be included in the bicell structure.

 成分Aとしては、リン酸残基を含む複合脂質であって、天然リン脂質、合成リン脂質、天然由来のリン脂質の不飽和炭素鎖を水素により飽和とした水素添加リン脂質等が挙げられる。上記リン脂質としては、例えば、ホスファチジルコリン、ホスファチジルエタノールアミン、ホスファチジルセリン、ホスファチジルイノシトール、リゾホスファチジルコリン、スフィンゴミエリン、卵黄レシチン、大豆レシチン等の天然リン脂質;ジラウロイルホスファチジルコリン、ジミリストイルホスファチジルコリン、ジパルミトイルホスファチジルコリン、ジステアロイルホスファチジルコリン、ジオレオイルホスファチジルコリン、パルミトイル・オレオイルホスファチジルコリン等の合成リン脂質;水素添加大豆レシチン、水素添加卵黄レシチン、水素添加ホスファチジルコリン、水素添加ホスファチジルセリン等の水素添加リン脂質等が挙げられる。このうち、保存安定性に優れる観点から、水素添加リン脂質が好ましく、水素添加大豆レシチンがより好ましい。成分Aは、一種のみを用いてもよいし、二種以上を用いてもよい。  Component A is a complex lipid containing a phosphate residue, such as a natural phospholipid, a synthetic phospholipid, or a hydrogenated phospholipid in which the unsaturated carbon chain of a naturally occurring phospholipid is saturated with hydrogen. Examples of the phospholipid include natural phospholipids such as phosphatidylcholine, phosphatidylethanolamine, phosphatidylserine, phosphatidylinositol, lysophosphatidylcholine, sphingomyelin, egg yolk lecithin, soybean lecithin; Synthetic phospholipids such as stearoyl phosphatidylcholine, dioleoyl phosphatidylcholine, palmitoyl oleoyl phosphatidylcholine; hydrogenated phospholipids such as hydrogenated soybean lecithin, hydrogenated egg yolk lecithin, hydrogenated phosphatidylcholine, hydrogenated phosphatidylserine, and the like. Among them, hydrogenated phospholipids are preferred, and hydrogenated soybean lecithin is more preferred, from the viewpoint of excellent storage stability. As the component A, only one type may be used, or two or more types may be used.

 成分Aとしては、市販品を用いることができる。水素添加大豆レシチンの市販品としては、例えば、商品名「COATSOME NC-21」、商品名「COATSOME NC-61」(以上、日油株式会社製)、商品名「NIKKOL レシノールS-10EX」、商品名「NIKKOL レシノールS-10E」、商品名「NIKKOL レシノールS-10M」(以上、日光ケミカルズ株式会社製)、商品名「ベイシス LS-60HR」(日清オイリオグループ株式会社製)等が挙げられる。  市 販 As the component A, a commercially available product can be used. Commercial products of hydrogenated soybean lecithin include, for example, trade name "COATSOME @ NC-21", trade name "COATSOME @ NC-61" (both manufactured by NOF Corporation), trade name "NIKKOL @ resinol S-10EX", trade name The trade name is "NIKKOL @ Resinol S-10E", the trade name "NIKKOL @ Resinol S-10M" (above, manufactured by Nikko Chemicals Co., Ltd.), and the trade name is "Basis @ LS-60HR" (manufactured by Nisshin Oillio Group Co., Ltd.).

 本発明の皮膚化粧料用組成物中の成分Aの含有割合は、特に限定されないが、本発明の皮膚化粧料用組成物の総量100質量%に対して、0.005質量%以上が好ましく、より好ましくは0.1質量%以上、さらに好ましくは0.2質量%以上である。上記含有割合が0.005質量%以上であると、バイセル構造を形成し、成分Fを安定に分散させ、保存安定性にも一層優れる。上記含有割合の上限は、3.0質量%以下が好ましく、より好ましくは2.0質量%以下、さらに好ましくは1.5質量%以下である。上記含有割合が3.0質量%以下であると、過度の粘度上昇を抑制し、分散性を一層向上させることができる。上記成分Aの含有割合は、本発明の皮膚化粧料用組成物中の全ての成分Aの含有割合の合計である。 The content ratio of the component A in the skin cosmetic composition of the present invention is not particularly limited, but is preferably 0.005% by mass or more based on 100% by mass of the total amount of the skin cosmetic composition of the present invention. It is more preferably at least 0.1% by mass, further preferably at least 0.2% by mass. When the content is 0.005% by mass or more, a bicell structure is formed, the component F is stably dispersed, and the storage stability is further improved. The upper limit of the content is preferably 3.0% by mass or less, more preferably 2.0% by mass or less, and even more preferably 1.5% by mass or less. When the content is 3.0% by mass or less, an excessive increase in viscosity can be suppressed, and the dispersibility can be further improved. The content ratio of the component A is the sum of the content ratios of all the components A in the skin cosmetic composition of the present invention.

[成分B]
 成分Bは「オキシエチレンの平均付加モル数が15~50のポリオキシエチレンステロールエーテル及び/又はオキシエチレンの平均付加モル数が15~50のポリオキシエチレンスタノールエーテル」である。すなわち、成分Bは、上記ポリオキシエチレンステロールエーテル及び上記ポリオキシエチレンスタノールエーテルのうちのいずれか一方又は両方である。成分Bは成分Aとの親和性が高く、成分Aと共に二分子膜を形成する。さらに、二分子膜の曲率を調整し、これによりバイセル構造の安定化に寄与すると推定される。成分Bとしては、酸化安定性に優れる観点から、ポリオキシエチレンスタノールエーテルがより好ましい。 
[Component B]
Component B is "polyoxyethylene sterol ether having an average addition mole number of oxyethylene of 15 to 50 and / or polyoxyethylene stanol ether having an average addition mole number of oxyethylene of 15 to 50". That is, the component B is one or both of the polyoxyethylene sterol ether and the polyoxyethylene stanol ether. Component B has a high affinity for component A and forms a bilayer with component A. Further, it is presumed that the curvature of the bilayer film is adjusted, thereby contributing to stabilization of the bicell structure. As component B, polyoxyethylene stanol ether is more preferred from the viewpoint of excellent oxidation stability.

 ポリオキシエチレンステロールエーテル又はポリオキシエチレンスタノールエーテルとは、ステロール又はスタノールにオキシエチレンを付加させたものである。ステロール又はスタノールに付加させるオキシエチレンの平均付加モル数は15~50であり、20~30が好ましい。  The polyoxyethylene sterol ether or polyoxyethylene stanol ether is obtained by adding oxyethylene to sterol or stanol. The average number of moles of oxyethylene to be added to sterol or stanol is 15 to 50, preferably 20 to 30.

 成分Bとしては、例えば、ポリオキシエチレンフィトステロールエーテル、ポリオキシエチレンフィトスタノールエーテル、ポリオキシエチレンコレステロールエーテル、ポリオキシエチレンコレスタノールエーテル等が挙げられる。このうち、植物性のポリオキシエチレンフィトステロールエーテル、ポリオキシエチレンフィトスタノールエーテルが好ましい。成分Bは、一種のみを用いてもよいし、二種以上を用いてもよい。  Component B includes, for example, polyoxyethylene phytosterol ether, polyoxyethylene phytostanol ether, polyoxyethylene cholesterol ether, polyoxyethylene cholestanol ether and the like. Among them, vegetable polyoxyethylene phytosterol ether and polyoxyethylene phytostanol ether are preferred. As the component B, only one type may be used, or two or more types may be used.

 成分Bとしては、市販品を用いてもよい。成分Bの市販品としては、例えば、商品名「NIKKOL BPS-20」、商品名「NIKKOL BPS-30」、商品名「NIKKOL BPSH-25」(以上、日光ケミカルズ株式会社製)等が挙げられる。  市 販 As the component B, a commercially available product may be used. Examples of commercially available products of Component B include “NIKKOL @ BPS-20”, trade name “NIKKOL @ BPS-30”, and trade name “NIKKOL @ BPSH-25” (all manufactured by Nikko Chemicals Co., Ltd.).

 本発明の皮膚化粧料用組成物中の成分Bの含有割合は、特に限定されないが、本発明の皮膚化粧料用組成物の総量100質量%に対して、0.03質量%以上が好ましく、より好ましくは1.0質量%以上である。上記含有割合が0.03質量%以上であると、バイセル構造の安定化に充分に寄与し、透明性及び保存安定性に一層優れる。上記含有割合の上限は、15.0質量%以下が好ましく、より好ましくは10.0質量%以下である。上記含有割合が15.0質量%以下であると、過度の粘度上昇を抑制し分散性を一層向上させることができる。上記成分Bの含有割合は、本発明の皮膚化粧料用組成物中の全ての成分Bの含有割合の合計である。 The content ratio of the component B in the skin cosmetic composition of the present invention is not particularly limited, but is preferably 0.03% by mass or more based on 100% by mass of the total amount of the skin cosmetic composition of the present invention, It is more preferably at least 1.0% by mass. When the content is 0.03% by mass or more, it sufficiently contributes to stabilization of the bicell structure, and is further excellent in transparency and storage stability. The upper limit of the content ratio is preferably 15.0% by mass or less, and more preferably 10.0% by mass or less. When the content ratio is 15.0% by mass or less, an excessive increase in viscosity can be suppressed, and the dispersibility can be further improved. The content ratio of the component B is the sum of the content ratios of all the component B in the skin cosmetic composition of the present invention.

 本発明の皮膚化粧料用組成物中の、成分Aに対する成分Bの質量比(B/A)は、5.5以上、好ましくは6.0以上、より好ましくは7.0以上である。また、上記質量比(B/A)は、18.0以下であり、好ましくは15.0以下、より好ましくは12.0以下である。上記質量比(B/A)が、上記範囲内であると、透明性及び保存安定性に一層優れる。 質量 The mass ratio (B / A) of the component B to the component A in the skin cosmetic composition of the present invention is 5.5 or more, preferably 6.0 or more, more preferably 7.0 or more. Further, the mass ratio (B / A) is 18.0 or less, preferably 15.0 or less, more preferably 12.0 or less. When the mass ratio (B / A) is within the above range, transparency and storage stability are more excellent.

[成分C]
 成分Cは「分岐鎖を有する炭素数12~24の1価の脂肪族アルコール」である。成分Cを使用することにより脂質二分子膜を柔軟にし、安定化に寄与するものと推測される。
[Component C]
Component C is “a monovalent aliphatic alcohol having a branched chain and having 12 to 24 carbon atoms”. It is presumed that the use of Component C softens the lipid bilayer membrane and contributes to stabilization.

 成分Cとしては、例えば、オクチルドデカノール、デシルテトラデカノール、イソステアリルアルコール等が挙げられる。中でも、保存安定性向上の観点から、オクチルドデカノール、デシルテトラデカノールが好ましい。成分Cは、一種のみを用いてもよいし、二種以上を用いてもよい。  Component C includes, for example, octyldodecanol, decyltetradecanol, isostearyl alcohol and the like. Among them, octyldodecanol and decyltetradecanol are preferred from the viewpoint of improving storage stability. As the component C, only one type may be used, or two or more types may be used.

 本発明の皮膚化粧料用組成物中の成分Cの含有割合は、特に限定されないが、本発明の皮膚化粧料用組成物の総量100質量%に対して、0.005質量%以上が好ましく、より好ましくは0.05質量%以上、さらに好ましくは0.1質量%以上である。上記含有割合が0.005質量%以上であると、保存安定性に一層優れる。上記含有割合の上限は、0.5質量%以下が好ましく、より好ましくは0.4質量%以下である。上記含有割合が0.5質量%以下であると、透明性を一層向上させる。上記成分Cの含有割合は、本発明の皮膚化粧料用組成物中の全ての成分Cの含有割合の合計である。 The content ratio of the component C in the skin cosmetic composition of the present invention is not particularly limited, but is preferably 0.005% by mass or more based on 100% by mass of the total amount of the skin cosmetic composition of the present invention. It is more preferably at least 0.05% by mass, and even more preferably at least 0.1% by mass. When the content is 0.005% by mass or more, the storage stability is further improved. The upper limit of the content ratio is preferably 0.5% by mass or less, more preferably 0.4% by mass or less. When the content is 0.5% by mass or less, the transparency is further improved. The content ratio of the component C is the sum of the content ratios of all the components C in the skin cosmetic composition of the present invention.

 本発明の皮膚化粧料用組成物中の、成分Aに対する成分Cの質量比(C/A)は、特に限定されないが、0.05以上が好ましく、より好ましくは0.1以上、さらに好ましくは0.15以上である。上記質量比(C/A)が、0.05以上であると保存安定性に一層優れる。上記質量比(C/A)の上限は、1.0以下が好ましく、より好ましくは0.7以下、さらに好ましくは0.5以下である。上記質量比(C/A)が、1.0以下であると、透明性に一層優れる。 The mass ratio (C / A) of the component C to the component A in the skin cosmetic composition of the present invention is not particularly limited, but is preferably 0.05 or more, more preferably 0.1 or more, and still more preferably. 0.15 or more. When the mass ratio (C / A) is 0.05 or more, the storage stability is further improved. The upper limit of the mass ratio (C / A) is preferably 1.0 or less, more preferably 0.7 or less, and even more preferably 0.5 or less. When the mass ratio (C / A) is 1.0 or less, transparency is further improved.

[成分D]
 成分Dは「プロピレングリコール、ジプロピレングリコール及び1,3-ブチレングリコールからなる群より選ばれた一種以上の多価アルコール」である。成分Dは皮膚化粧料用組成物の製造時における他の成分の溶媒として機能する。特に、成分Dの特定3成分を用いることにより、他の成分を分散した場合の分散液の粘度上昇が抑えられ、分散性が向上する。成分Dは、一種のみを用いてもよいし、二種以上を用いてもよい。 
[Component D]
Component D is "one or more polyhydric alcohols selected from the group consisting of propylene glycol, dipropylene glycol and 1,3-butylene glycol". Component D functions as a solvent for other components during production of the skin cosmetic composition. In particular, by using the specified three components of the component D, an increase in the viscosity of the dispersion when other components are dispersed is suppressed, and the dispersibility is improved. As the component D, only one type may be used, or two or more types may be used.

 本発明の皮膚化粧料用組成物中の成分Dの含有割合は、特に限定されないが、本発明の皮膚化粧料用組成物の総量100質量%に対して、0.25質量%以上が好ましく、より好ましくは3.0質量%以上、さらに好ましくは5.0質量%以上である。上記含有割合の上限は、30.0質量%以下が好ましく、より好ましくは25.0質量%以下、さらに好ましくは15.0質量%以下である。上記含有割合が上記範囲内であると、透明性及び保存安定性に一層優れる。上記成分Dの含有割合は、本発明の皮膚化粧料用組成物中の全ての成分Dの含有割合の合計である。 The content ratio of the component D in the skin cosmetic composition of the present invention is not particularly limited, but is preferably 0.25% by mass or more based on 100% by mass of the total amount of the skin cosmetic composition of the present invention. It is more preferably at least 3.0% by mass, and even more preferably at least 5.0% by mass. The upper limit of the content is preferably 30.0% by mass or less, more preferably 25.0% by mass or less, and still more preferably 15.0% by mass or less. When the content is in the above range, transparency and storage stability are further improved. The content ratio of the component D is the sum of the content ratios of all the components D in the skin cosmetic composition of the present invention.

 本発明の皮膚化粧料用組成物中の、成分Aに対する成分Dの質量比(D/A)は、特に限定されないが、8.0以上が好ましく、より好ましくは10.0以上である。上記質量比(D/A)の上限は、60.0以下が好ましく、より好ましくは30.0以下、さらに好ましくは20.0以下である。上記質量比(D/A)が上記範囲内であると、皮膚化粧料用組成物の白濁防止に一層優れる。 質量 The mass ratio (D / A) of the component D to the component A in the skin cosmetic composition of the present invention is not particularly limited, but is preferably 8.0 or more, more preferably 10.0 or more. The upper limit of the mass ratio (D / A) is preferably 60.0 or less, more preferably 30.0 or less, and even more preferably 20.0 or less. When the mass ratio (D / A) is within the above range, the composition for skin cosmetics is more excellent in preventing cloudiness.

[成分E]
 成分Eは「水」である。水を使用することにより、本発明の皮膚化粧料用組成物にみずみずしさとさっぱり感を付与することができ、さらには本発明の皮膚化粧料用組成物を水系ローション等の皮膚化粧料に適用することができる。 
[Component E]
Component E is "water". By using water, freshness and freshness can be imparted to the skin cosmetic composition of the present invention, and further the skin cosmetic composition of the present invention is applied to skin cosmetics such as aqueous lotions. be able to.

 本発明の皮膚化粧料用組成物中の成分Eの含有割合は、特に限定されないが、本発明の皮膚化粧料用組成物の総量100質量%に対して、55.0質量%以上が好ましく、より好ましくは60.0質量%以上、さらに好ましくは65.0質量%以上である。上記含有割合は、95.0質量%以下が好ましく、より好ましくは90.0質量%以下、さらに好ましくは85.0質量%以下である。上記配合割合が、上記範囲内であると、水系ローションへ適用する際の簡便性及びさっぱりとした使用感が得られるため好ましい。 The content ratio of the component E in the skin cosmetic composition of the present invention is not particularly limited, but is preferably 55.0% by mass or more based on 100% by mass of the total amount of the skin cosmetic composition of the present invention. It is more preferably at least 60.0% by mass, still more preferably at least 65.0% by mass. The content is preferably 95.0% by mass or less, more preferably 90.0% by mass or less, and still more preferably 85.0% by mass or less. It is preferable that the compounding ratio be within the above range, since simplicity and a refreshing feeling upon application to an aqueous lotion can be obtained.

[成分F]
 成分Fは「ステロール」である。成分Fは、二分子膜の曲率を調整し、これによりバイセル構造の安定化に寄与すると推定される。また、皮膚のバリア機能向上等のための有効成分としても配合される。
[Component F]
Component F is a "sterol". Component F is presumed to adjust the curvature of the bilayer and thereby contribute to the stabilization of the bicell structure. In addition, it is also blended as an active ingredient for improving skin barrier function and the like.

 成分Fとしては、例えば、動物ステロール、植物ステロール(フィトステロール)等が挙げられる。動物ステロールとしては、例えば、コレステロール、コレスタノール、7-デヒドロコレステロール等が挙げられる。また、植物ステロールとしては、例えば、シトステロール、スチグマステロール、フコステロール、スピナステロール、ブラシカステロール等が挙げられる。成分Fは、一種のみを用いてもよいし、二種以上を用いてもよい。  The component F includes, for example, animal sterol, plant sterol (phytosterol) and the like. Animal sterols include, for example, cholesterol, cholestanol, 7-dehydrocholesterol and the like. Examples of the plant sterol include sitosterol, stigmasterol, fucosterol, spinasterol, and brassicasterol. As the component F, only one type may be used, or two or more types may be used.

 成分Fとしては、市販品を用いることができる。成分Fの市販品としては、例えば、商品名「コレステロールJSQI」、商品名「日本薬局方コレステロール」(以上、日本精化株式会社製)、商品名「フィトステロール」(エーザイフード・ケミカル株式会社製)、商品名「フィトステロール-SKP」(タマ生化学株式会社製)等が挙げられる。  市 販 As the component F, a commercially available product can be used. Examples of commercial products of Component F include, for example, trade name “Cholesterol JSQI”, trade name “Cholesterol of Japanese Pharmacopoeia” (all manufactured by Nippon Seika Co., Ltd.), and trade name “phytosterol” (manufactured by Eisai Food Chemical Co., Ltd.) And the trade name "Phytosterol-SKP" (manufactured by Tama Seikagaku Co., Ltd.).

 本発明の皮膚化粧料用組成物中の成分Fの含有割合は、特に限定されないが、本発明の皮膚化粧料用組成物の総量100質量%に対して、0.01質量%以上が好ましく、より好ましくは0.1質量%以上、さらに好ましくは0.2質量%以上である。上記含有割合が、0.01質量%以上であると、皮膚にバリア機能等を付与することができる。上記含有割合の上限は、2.0質量%以下が好ましく、より好ましくは1.0質量%以下、さらに好ましくは0.6質量%以下である。上記質量割合が、2.0質量%以下であると、保存安定性の向上に一層優れる。上記成分Fの含有割合は、本発明の皮膚化粧料用組成物中の全ての成分Fの含有割合の合計である。 The content ratio of the component F in the skin cosmetic composition of the present invention is not particularly limited, but is preferably 0.01% by mass or more based on 100% by mass of the total amount of the skin cosmetic composition of the present invention, It is more preferably at least 0.1% by mass, further preferably at least 0.2% by mass. When the content is 0.01% by mass or more, a barrier function or the like can be imparted to the skin. The upper limit of the content is preferably 2.0% by mass or less, more preferably 1.0% by mass or less, and even more preferably 0.6% by mass or less. When the mass ratio is 2.0% by mass or less, the storage stability is further improved. The content ratio of the component F is the sum of the content ratios of all the components F in the skin cosmetic composition of the present invention.

[成分G]
 成分Gは「油分」である。成分Gとしては、例えば、植物油、エステル油、シリコーン油、炭化水素油、ロウ、高級脂肪酸、成分C以外の高級アルコール等が挙げられる。成分Gは本発明の皮膚化粧料用組成物において、肌の水分の蒸散を防ぎ、角質を柔軟にするなどのエモリエント成分として用いられる。なお成分Gには、成分Fに該当するものは含まれないものとする。成分Gは、一種のみを用いてもよいし、二種以上を用いてもよい。
[Component G]
Component G is “oil”. Component G includes, for example, vegetable oil, ester oil, silicone oil, hydrocarbon oil, wax, higher fatty acid, higher alcohol other than component C, and the like. Component G is used as an emollient component in the skin cosmetic composition of the present invention, for example, to prevent evaporation of skin moisture and to soften keratin. The component G does not include the component F. As the component G, only one type may be used, or two or more types may be used.

 上記植物油としては、例えば、マカデミアナッツ油、ユーカリ油、ヤシ油、アボカド油、サフラワー油、オリーブ油、パーム油、パーム核油、ククイナッツ油、シア脂(シアバター)、カカオバター、アーモンド油、ヒマワリ油、ローズヒップ油、オリーブスクワラン、カメリアオイル、キウイフルーツシード油、ツバキ油、杏仁油、ゴマ油、大豆油、ホホバ油、ヒマシ油、ヘーゼルナッツ油、メドウフォーム油、ハッカ油、アルガンオイル、カロットオイル、ラベンダー油、シュガースクワラン、ダマスクバラ花ロウ、センチフォリアバラ花ロウ、ソケイ花ワックス、椿油、これらの水素添加物(例えば、水素添加ヒマシ油、水素添加ホホバ油、水素添加パーム油、水素添加アボカド油、水素添加大豆油等)等が挙げられる。 Examples of the vegetable oil include macadamia nut oil, eucalyptus oil, coconut oil, avocado oil, safflower oil, olive oil, palm oil, palm kernel oil, kukui nut oil, shea butter (shea butter), cocoa butter, almond oil, and sunflower oil. , Rose hip oil, olive squalane, camelia oil, kiwi fruit seed oil, camellia oil, apricot kernel oil, sesame oil, soybean oil, jojoba oil, castor oil, hazelnut oil, meadowfoam oil, peppermint oil, argan oil, carrot oil, lavender Oil, sugar squalane, damask rose flower wax, centifolia rose flower wax, scotch flower wax, camellia oil, hydrogenated products thereof (for example, hydrogenated castor oil, hydrogenated jojoba oil, hydrogenated palm oil, hydrogenated avocado oil, Hydrogenated soybean oil and the like).

 上記エステル油としては、例えば、オレイン酸エチル、ミリスチン酸イソプロピル、パルミチン酸イソプロピル、ミリスチン酸ミリスチル、パルミチン酸セチル、パルミチン酸2-エチルヘキシル、ミリスチン酸オクチルドデシル、イソステアリン酸イソプロピル、イソステアリン酸プロピレングリコール、2-エチルヘキサン酸セチル、トリ2-エチルヘキサン酸グリセリル、トリ(カプリル酸/カプリン酸)グリセリル、イソノナン酸イソノニル、アジピン酸ジイソプロピル、テトラオクタン酸ペンタエリスリチル、テトライソステアリン酸ペンタエリトリット、リンゴ酸ジイソステアリル、トリエチルヘキサン酸エリスリチル、ヒドロキシステアリン酸2-エチルヘキシル、ヘキサ(ヒドロキシステアリン酸/ステアリン酸/ロジン酸)ジペンタエリスリチル、テトラ(ヒドロキシステアリン酸/イソステアリン酸)ジペンタエリスリチル、ヘキサヒドロキシステアリン酸ジペンタエリスリチル、(エチルヘキサン酸/ステアリン酸/アジピン酸)グリセリル、トリ(カプリル酸/カプリン酸/ミリスチン酸/ステアリン酸)グリセリル、ヘキサ(ベヘン酸/安息香酸/エチルヘキサン酸)ジペンタエリスリチル、安息香酸アルキル(C12-15)等が挙げられる。 Examples of the ester oil include ethyl oleate, isopropyl myristate, isopropyl palmitate, myristyl myristate, cetyl palmitate, 2-ethylhexyl palmitate, octyl dodecyl myristate, isopropyl isostearate, propylene glycol isostearate, and propylene glycol isostearate. Cetyl ethylhexanoate, glyceryl tri-2-ethylhexanoate, glyceryl tri (caprylate / caprate), isononyl isononanoate, diisopropyl adipate, pentaerythrityl tetraoctanoate, pentaerythrityl tetraisostearate, diisostearyl malate , Erythrityl triethylhexanoate, 2-ethylhexyl hydroxystearate, hexa (hydroxystearic acid / stearic acid / rosin) ) Dipentaerythrityl, tetra (hydroxystearic acid / isostearic acid) dipentaerythrityl, hexahydroxystearic acid dipentaerythrityl, (ethylhexanoic acid / stearic acid / adipate) glyceryl, tri (caprylic / capric / myristic / stearic) glyceryl, hexa (Behenic acid / benzoic acid / ethylhexanoic acid) dipentaerythrityl, alkyl benzoate (C12-15) and the like.

 上記シリコーン油としては、特に限定されないが、例えば、メチルポリシロキサン、高重合メチルポリシロキサン等のジメチルシリコーン油;メチルフェニルポリシロキサン等のメチルフェニルシリコーン油;メチルシクロポリシロキサン、オクタメチルシクロテトラシロキサン、デカメチルシクロペンタシロキサン、ドデカメチルシクロヘキサシロキサン等の環状シリコーン油;アミノプロピルメチルシロキサン・ジメチルシロキサン共重合体、アミノエチルアミノプロピルシロキサン・ジメチルシロキサン共重合体、アミノエチルアミノプロピルメチルシロキサン・ジメチルシロキサン共重合体等のアミノ変性シリコーン、カルボキシ変性シリコーン、脂肪酸変性シリコーン、アルコール変性シリコーン、脂肪族アルコール変性シリコーン、エポキシ変性シリコーン、フッ素変性シリコーン、アルキル変性シリコーン等の変性シリコーン;メチルハイドロジェンポリシロキサン、ジメチコノール等が挙げられる。 Examples of the silicone oil include, but are not particularly limited to, dimethyl silicone oil such as methylpolysiloxane and highly polymerized methylpolysiloxane; methylphenyl silicone oil such as methylphenylpolysiloxane; methylcyclopolysiloxane, octamethylcyclotetrasiloxane; Cyclic silicone oils such as decamethylcyclopentasiloxane and dodecamethylcyclohexasiloxane; aminopropylmethylsiloxane / dimethylsiloxane copolymer, aminoethylaminopropylsiloxane / dimethylsiloxane copolymer, aminoethylaminopropylmethylsiloxane / dimethylsiloxane Amino-modified silicone, carboxy-modified silicone, fatty acid-modified silicone, alcohol-modified silicone, aliphatic alcohol-modified silicone such as polymers Emissions, epoxy-modified silicone, fluorine-modified silicones, modified silicones and alkyl-modified silicones; methylhydrogenpolysiloxane, dimethiconol, and the like.

 上記炭化水素油としては、例えば、α-オレフィンオリゴマー、ワセリン、イソパラフィン、軽質イソパラフィン、軽質流動イソパラフィン、スクワラン、合成スクワラン、植物性スクワラン、流動イソパラフィン、流動パラフィン等、水添ポリイソブテン、水添(テトラデセニル/メチルペンタデセン)、イソドデカン等が挙げられる。 Examples of the hydrocarbon oil include α-olefin oligomer, petrolatum, isoparaffin, light isoparaffin, light liquid isoparaffin, squalane, synthetic squalane, vegetable squalane, liquid isoparaffin, liquid paraffin, hydrogenated polyisobutene, hydrogenated (tetradecenyl / Methylpentadecene), isododecane and the like.

 上記ロウとしては、例えば、カルナウバロウ、キャンデリラロウ、ミツロウ、コメヌカロウ、セラックロウ、鯨ロウ、ラノリン、ヒマワリ種子ロウ等が挙げられる。 Examples of the wax include carnauba wax, candelilla wax, beeswax, rice bran wax, shellac wax, whale wax, lanolin, sunflower seed wax and the like.

 上記高級脂肪酸としては、例えば、ラウリン酸、ミリスチン酸、パルミチン酸、ステアリン酸、イソステアリン酸、オレイン酸等が挙げられる。 Examples of the higher fatty acids include lauric acid, myristic acid, palmitic acid, stearic acid, isostearic acid, and oleic acid.

 上記成分C以外の高級アルコールとしては、例えば、セチルアルコール、ステアリルアルコール、ミリスチルアルコール、オレイルアルコール等が挙げられる。 高級 Examples of higher alcohols other than the above-mentioned component C include cetyl alcohol, stearyl alcohol, myristyl alcohol, oleyl alcohol and the like.

 中でも、成分Gとしては、高極性の油分を含むことが好ましい。また、上記高極性の油分は、ステロール骨格を有することがより好ましい。成分Gとして高極性の油分を含むと、エモリエント効果がより一層向上する。高極性の油分は、一種のみを用いてもよいし、二種以上を用いてもよい。 Among them, component G preferably contains a highly polar oil component. Further, the highly polar oil component more preferably has a sterol skeleton. When a highly polar oil component is contained as the component G, the emollient effect is further improved. As the highly polar oil, only one kind may be used, or two or more kinds may be used.

 上記高極性の油分としては、植物由来、動物由来、及び鉱物由来の内のいずれも使用可能である。極性油脂としては、例えば、水添パーム油、水添ホホバ油、シア脂、(アジピン酸・2-エチルヘキサン酸・ステアリン酸)グリセリルオリゴエステル、マカデミアナッツ油脂肪酸フィトステリル、トリカプリル酸グリセリル、トリカプリン酸グリセリル、トリミリスチン酸グリセリル、トリステアリン酸グリセリル、オレイン酸フィトステリル、ヒドロキシステアリン酸ジペンタエリスリチル、ステアリン酸ジペンタエリスリチル、ロジン酸ジペンタエリスリチル、ヘキサヒドロキシステアリン酸ジペンタエリスリチル等が挙げられる。本発明の皮膚化粧料用組成物のエモリエント効果をより一層高める観点からは、オレイン酸フィトステリルが好ましい。 As the highly polar oil component, any of plant-derived, animal-derived, and mineral-derived oils can be used. Examples of polar fats and oils include hydrogenated palm oil, hydrogenated jojoba oil, shea butter, (adipic acid / 2-ethylhexanoic acid / stearic acid) glyceryl oligoester, macadamia nut oil fatty acid phytosteryl, glyceryl tricaprylate, glyceryl tricaprate, Glyceryl trimyristate, glyceryl tristearate, phytosteryl oleate, dipentaerythrityl hydroxystearate, dipentaerythrityl stearate, dipentaerythrityl rosinate, dipentaerythrityl hexahydroxystearate, and the like. Phytosteryl oleate is preferred from the viewpoint of further enhancing the emollient effect of the skin cosmetic composition of the present invention.

 本発明の皮膚化粧料用組成物中の成分Gの含有割合は、特に限定されないが、本発明の皮膚化粧料用組成物の総量100質量%に対して、0.01質量%以上が好ましく、より好ましくは0.05質量%以上である。上記含有割合が0.01質量%以上であると、保湿や角質柔軟などのエモリエント効果を一層発揮する。上記含有割合は、0.3質量%以下が好ましく、より好ましくは0.2質量%以下である。上記含有割合が0.3質量%以下であると、保存安定性により一層優れる。上記成分Gの含有割合は、本発明の皮膚化粧料用組成物中の全ての成分Gの含有割合の合計である。 The content ratio of the component G in the skin cosmetic composition of the present invention is not particularly limited, but is preferably 0.01% by mass or more based on 100% by mass of the total amount of the skin cosmetic composition of the present invention. More preferably, it is 0.05% by mass or more. When the content is 0.01% by mass or more, emollient effects such as moisturizing and keratin softening are further exhibited. The content is preferably 0.3% by mass or less, more preferably 0.2% by mass or less. When the content is 0.3% by mass or less, the storage stability is further improved. The content ratio of the component G is the sum of the content ratios of all the components G in the skin cosmetic composition of the present invention.

 本発明の皮膚化粧料用組成物中の、成分Aに対する成分Gの質量比(G/A)は、特に限定されないが、0.01以上が好ましく、より好ましくは0.02であり、さらに好ましくは0.05以上である。上記質量比(G/A)は、1.0以下が好ましく、より好ましくは0.8以下、さらに好ましくは0.5以下である。上記質量比(G/A)が、上記範囲内であると保存安定性に一層優れる。 The mass ratio (G / A) of the component G to the component A in the skin cosmetic composition of the present invention is not particularly limited, but is preferably 0.01 or more, more preferably 0.02, and still more preferably. Is 0.05 or more. The mass ratio (G / A) is preferably 1.0 or less, more preferably 0.8 or less, and even more preferably 0.5 or less. When the mass ratio (G / A) is within the above range, the storage stability is more excellent.

[成分H]
 成分Hは、「オキシエチレンの平均付加モル数が5~30のポリオキシエチレン硬化ヒマシ油」である。成分Hは、本発明の皮膚化粧料用組成物において、二分子膜の曲率を調整し、これによりバイセル構造の安定化に寄与すると推定される。特に、成分Gを安定的に膜中に閉じ込め、保存安定性を高める効果を発揮する。成分Hは、一種のみを用いてもよいし、二種以上を用いてもよい。
[Component H]
Component H is "polyoxyethylene hydrogenated castor oil having an average addition mole number of oxyethylene of 5 to 30". Component H is presumed to adjust the curvature of the bilayer in the skin cosmetic composition of the present invention, thereby contributing to stabilization of the bicell structure. In particular, it exerts an effect of stably confining the component G in the film and improving storage stability. As the component H, only one type may be used, or two or more types may be used.

 成分Hのオキシエチレンの平均付加モル数は5~30である。平均付加モル数は好ましくは10以上、より好ましくは15以上、好ましくは25以下である。成分Hのオキシエチレンの平均付加モル数が上記の好ましい範囲内であると、油分を安定的にバイセル中に閉じ込め、保存安定性を高める効果を一層発揮する。中でも、成分Hとしては、オキシエチレンの平均付加モル数が20のポリオキシエチレン硬化ヒマシ油が最も好ましい。 平均 The average number of moles of oxyethylene added as the component H is 5 to 30. The average number of moles added is preferably 10 or more, more preferably 15 or more, and preferably 25 or less. When the average number of added moles of oxyethylene of the component H is within the above-mentioned preferred range, the oil component is more stably confined in the bicell, and the effect of increasing the storage stability is further exhibited. Among them, the component H is most preferably a polyoxyethylene hydrogenated castor oil having an average addition number of oxyethylene of 20.

 成分HのHLB(Hydrophile-Lipophile Balance)値は、特に限定されないが、例えば6.0~11.0、好ましくは6.5~10.5である。HLB値が上記範囲である成分Hを使用すると、保存安定性に寄与する。成分HのHLB値が親油性を示すほど、より良好な保存安定性を発揮する。なお、上記HLB値は、グリフィン(Griffin)法により算出することができる。 The HLB (Hydrophil-Lipophile Balance) value of the component H is not particularly limited, but is, for example, 6.0 to 11.0, and preferably 6.5 to 10.5. Use of the component H having an HLB value in the above range contributes to storage stability. The more the HLB value of the component H indicates lipophilicity, the better the storage stability. Note that the HLB value can be calculated by the Griffin method.

 本発明の皮膚化粧料用組成物中の成分Hの含有割合は、特に限定されないが、本発明の皮膚化粧料用組成物の総量100質量%に対して、0.05質量%以上が好ましく、より好ましくは0.5質量%以上である。上記含有割合は、5.0質量%以下が好ましく、より好ましくは3.0質量%以下、さらに好ましくは2.0質量%以下である。上記含有割合が、上記範囲内であると成分Gを安定的に脂質二分子膜中に閉じ込める効果に一層優れる。上記成分Hの含有割合は、本発明の皮膚化粧料用組成物中の全ての成分Hの含有割合の合計である。 The content ratio of the component H in the skin cosmetic composition of the present invention is not particularly limited, but is preferably 0.05% by mass or more based on 100% by mass of the total amount of the skin cosmetic composition of the present invention. It is more preferably at least 0.5% by mass. The content is preferably 5.0% by mass or less, more preferably 3.0% by mass or less, and further preferably 2.0% by mass or less. When the content is within the above range, the effect of stably confining the component G in the lipid bilayer membrane is more excellent. The content ratio of the component H is the sum of the content ratios of all the component Hs in the skin cosmetic composition of the present invention.

[成分I]
 成分Iは、「グリセリンモノ2-エチルヘキシルエーテル」(「オクトキシグリセリン」とも称される。)である。成分Iを含有する場合、バイセル構造の脂質二分子膜内に入り込むため、膜形状に柔軟性が付与されると推定される。このため、本発明の皮膚化粧料用組成物は、透明性と保存安定性がより一層向上する。
[Component I]
Component I is "glycerin mono 2-ethylhexyl ether" (also referred to as "octoxyglycerin"). When component I is contained, it is presumed that flexibility is imparted to the membrane shape because it penetrates into the bicellular lipid bilayer membrane. For this reason, the composition for skin cosmetics of the present invention further improves transparency and storage stability.

 本発明の皮膚化粧料用組成物が成分Iを含有する場合、本発明の皮膚化粧料用組成物中の成分Iの含有割合は、特に限定されないが、本発明の皮膚化粧料用組成物の総量100質量%に対して、0.01質量%以上が好ましく、より好ましくは0.05質量%以上、さらに好ましくは0.1質量%以上である。上記含有割合が、0.01質量%以上であると、透明性と保存安定性に一層優れる。上記含有割合の上限は、2.0質量%以下が好ましく、より好ましくは1.5質量%以下、さらに好ましくは1.0質量%以下である。 上記含有割合が2.0質量%以下であると、より低刺激性の剤とすることができる。 When the skin cosmetic composition of the present invention contains Component I, the content ratio of Component I in the skin cosmetic composition of the present invention is not particularly limited. The amount is preferably 0.01% by mass or more, more preferably 0.05% by mass or more, and still more preferably 0.1% by mass or more, based on the total amount of 100% by mass. When the content is 0.01% by mass or more, transparency and storage stability are more excellent. The upper limit of the content ratio is preferably 2.0% by mass or less, more preferably 1.5% by mass or less, and further preferably 1.0% by mass or less. (4) When the content is 2.0% by mass or less, a less irritating agent can be obtained.

[成分J]
 成分Jは、「炭素数5~10の1,2-アルカンジオール」である。成分Jを含有する場合、バイセル構造の脂質二分子膜内に入り込むため、膜形状に柔軟性が付与されると推定される。このため、本発明の皮膚化粧料用組成物は、透明性と保存安定性がより一層向上する。
[Component J]
Component J is "1,2-alkanediol having 5 to 10 carbon atoms". When component J is contained, it is presumed that flexibility is imparted to the membrane shape because it enters the bilayer lipid bilayer membrane. For this reason, the composition for skin cosmetics of the present invention further improves transparency and storage stability.

 成分Jとしては、例えば、1,2-ペンタンジオール、1,2-ヘキサンジオール、1,2-オクタンジオール、1,2-デカンジオール等が挙げられる。成分Jは、一種のみを用いてもよいし、二種以上を用いてもよい。  As the component J, for example, 1,2-pentanediol, 1,2-hexanediol, 1,2-octanediol, 1,2-decanediol and the like can be mentioned. As the component J, only one type may be used, or two or more types may be used.

 本発明の皮膚化粧料用組成物が成分Jを含有する場合、本発明の皮膚化粧料用組成物中の成分Jの含有割合は、特に限定されないが、本発明の皮膚化粧料用組成物の総量100質量%に対して、0.01質量%以上が好ましく、より好ましくは0.1質量%以上、さらに好ましくは0.2質量%以上である。上記含有割合が、0.01質量%以上であると、透明性と保存安定性に一層優れる。上記含有割合の上限は、2.0質量%以下が好ましく、より好ましくは1.0質量%以下、さらに好ましくは0.7質量%以下である。上記含有割合が2.0質量%以下であると、より低刺激性の剤とすることができる。上記成分Jの含有割合は、本発明の皮膚化粧料用組成物中の全ての成分Jの含有割合の合計である。 When the skin cosmetic composition of the present invention contains the component J, the content ratio of the component J in the skin cosmetic composition of the present invention is not particularly limited. The amount is preferably 0.01% by mass or more, more preferably 0.1% by mass or more, and still more preferably 0.2% by mass or more based on the total amount of 100% by mass. When the content is 0.01% by mass or more, transparency and storage stability are more excellent. The upper limit of the content is preferably 2.0% by mass or less, more preferably 1.0% by mass or less, and even more preferably 0.7% by mass or less. When the content is 2.0% by mass or less, a more irritating agent can be obtained. The content ratio of the component J is the sum of the content ratios of all the components J in the skin cosmetic composition of the present invention.

[その他の成分]
 本発明の皮膚化粧料用組成物には、上記成分A~J以外のその他の成分がさらに含有されていてもよい。上記その他の成分としては、特に限定されないが、例えば、成分H以外の界面活性剤(カチオン界面活性剤、アニオン界面活性剤、ノニオン界面活性剤、両性界面活性剤等)、低級アルコール、成分C以外の高級アルコール、成分D以外の多価アルコール、紫外線吸収剤、粉体、酸化防止剤、防腐剤、香料、着色剤、キレート剤、清涼剤、増粘剤、ビタミン類、中和剤、アミノ酸、pH調整剤、美白剤、抗炎症剤、消臭剤、動植物抽出物、金属イオン封鎖剤などの添加剤などが挙げられる。上記その他の成分は、一種のみを用いてもよいし、二種以上を用いてもよい。 
[Other ingredients]
The skin cosmetic composition of the present invention may further contain other components other than the above components A to J. The other components are not particularly limited, but include, for example, surfactants other than component H (cationic surfactant, anionic surfactant, nonionic surfactant, amphoteric surfactant, etc.), lower alcohols, other than component C Higher alcohols, polyhydric alcohols other than component D, ultraviolet absorbers, powders, antioxidants, preservatives, fragrances, coloring agents, chelating agents, cooling agents, thickeners, vitamins, neutralizing agents, amino acids, Additives such as pH adjusters, whitening agents, anti-inflammatory agents, deodorants, plant and animal extracts, sequestering agents, and the like. As the other components, only one kind may be used, or two or more kinds may be used.

 本発明の皮膚化粧料用組成物の外観は、審美性の観点から、透明の状態のものが好ましい。また、本発明の皮膚化粧料用組成物の透明性が高いことは、配合された油分の凝集やクリーミングが生じていないことを意味し、非常に安定した状態であることを示している。このため本発明の皮膚化粧料用組成物の透明性は保存安定性の指標ともなる。 外 観 The skin cosmetic composition of the present invention preferably has a transparent appearance from the viewpoint of aesthetics. Further, the high transparency of the composition for skin cosmetics of the present invention means that the incorporated oil does not agglomerate or cream, and indicates that the composition is in a very stable state. For this reason, the transparency of the skin cosmetic composition of the present invention also serves as an index of storage stability.

 本発明の皮膚化粧料用組成物中においては、成分A(リン脂質)はミセルの一形態であるバイセル構造を形成する。バイセル構造とは、リン脂質で構成されたディスク状の脂質二分子膜である。本発明の皮膚化粧料用組成物におけるバイセル構造は、ミセルとリポソームの中間の、20~50nm程度の粒径を有する。上記バイセル構造は、脂質二分子膜内に油分を配合できるため、ミセルよりも、より多くの油分を配合できる。加えて、リポソームほどの粒径を有さないため、保存安定性にも優れる。また、上記バイセル構造であれば、透明性も損なわれることがない。 成分 In the skin cosmetic composition of the present invention, component A (phospholipid) forms a bicellular structure which is a form of micelle. The bicell structure is a disk-shaped lipid bilayer composed of phospholipids. The bicellular structure in the skin cosmetic composition of the present invention has a particle size of about 20 to 50 nm, which is between micelles and liposomes. In the bicell structure, since an oil component can be compounded in the lipid bilayer membrane, a larger amount of oil component can be compounded than a micelle. In addition, since it does not have the particle size of liposomes, it has excellent storage stability. Further, with the bicell structure, transparency is not impaired.

 また、上記の理由から、本発明の皮膚化粧料用組成物は、リン脂質から形成されたリポソームを含有していない皮膚化粧料用組成物であることが好ましい。 か ら Further, for the above reasons, the skin cosmetic composition of the present invention is preferably a skin cosmetic composition that does not contain liposomes formed from phospholipids.

 本発明の皮膚化粧料用組成物のpHは、特に限定されないが、例えば、25℃において5.0~8.0であることが好ましい。  PH The pH of the skin cosmetic composition of the present invention is not particularly limited, but is preferably, for example, 5.0 to 8.0 at 25 ° C.

 本発明の皮膚化粧料用組成物の粘度は、特に限定されないが、例えば、25℃での粘度が0.5~1000mPa・sであることが好ましく、0.5~500mPa・sであることがより好ましい。粘度測定はB型粘度計を用い、粘度に合ったローターを選択し、回転数60r/minで実施する。  The viscosity of the composition for skin cosmetics of the present invention is not particularly limited. For example, the viscosity at 25 ° C. is preferably 0.5 to 1000 mPa · s, and more preferably 0.5 to 500 mPa · s. More preferred. The viscosity is measured at a rotational speed of 60 r / min by using a B-type viscometer, selecting a rotor suitable for the viscosity.

 本発明の皮膚化粧料用組成物のバイセル構造の平均粒子径は、特に限定されないが、20nm以上が好ましく、より好ましくは30nm以上、さらに好ましくは40nm以上である。上記平均粒子径の下限が、20nm以上であることにより、バイセル構造内に成分Gを取り込むスペースを確保することができる。上記平均粒子径の上限は、好ましくは100nm以下、より好ましくは、90nm以下、さらに好ましくは80nm以下である。上記平均粒子径の上限が100nm以下であることにより、保存安定性と透明性により優れたものとなる。 平均 The average particle size of the bicell structure of the skin cosmetic composition of the present invention is not particularly limited, but is preferably 20 nm or more, more preferably 30 nm or more, and further preferably 40 nm or more. When the lower limit of the average particle diameter is 20 nm or more, a space for incorporating the component G in the bicell structure can be secured. The upper limit of the average particle diameter is preferably 100 nm or less, more preferably 90 nm or less, and still more preferably 80 nm or less. When the upper limit of the average particle diameter is 100 nm or less, the storage stability and the transparency are more excellent.

 上記平均粒子径(nm)の測定は、動的光散乱光度計や透過型電子顕微鏡(TEM)を用いて行うことができる。 The above average particle diameter (nm) can be measured using a dynamic light scattering photometer or a transmission electron microscope (TEM).

 本発明の皮膚化粧料用組成物を調製するには、上記各構成成分を混合し、公知の方法、例えばホモミキサーを用いて攪拌することにより製造することができる。  皮膚 In order to prepare the skin cosmetic composition of the present invention, the composition can be produced by mixing the above-mentioned components and stirring with a known method, for example, using a homomixer.

 また、本発明の皮膚化粧料用組成物を、皮膚化粧料に使用される成分と共に混合等することによって、化粧水等の皮膚化粧料を製造することができる。すなわち、本発明の皮膚化粧料用組成物は、皮膚化粧料の製造に用いる原料(所謂、中間原料)とすることができる。本発明の皮膚化粧料用組成物を用いることにより、水系や低粘度の分散媒にも安定して分散させることができるため、成分Gを皮膚化粧料中に配合させることができる。また、本発明の皮膚化粧料用組成物は、それ自体で皮膚化粧料として使用することもできる。  皮膚 Further, by mixing the composition for skin cosmetics of the present invention with components used in skin cosmetics, skin cosmetics such as lotion can be produced. That is, the composition for skin cosmetics of the present invention can be used as a raw material (so-called intermediate raw material) used in the production of skin cosmetics. By using the composition for skin cosmetics of the present invention, the composition can be stably dispersed in an aqueous or low-viscosity dispersion medium, so that the component G can be incorporated into the skin cosmetics. Moreover, the composition for skin cosmetics of the present invention can be used as a skin cosmetic as such.

 本発明においては、上記の本発明の皮膚化粧料用組成物を含有する皮膚化粧料が得られる。なお、本明細書においては、上記「本発明の皮膚化粧料用組成物を含有する皮膚化粧料」を「本発明の皮膚化粧料」と称する場合がある。本発明の皮膚化粧料100質量%中の本発明の皮膚化粧料用組成物の含有量は、特に限定されないが、好ましくは0.1~100質量%、より好ましくは0.5~10.0質量%とすることができる。 In the present invention, a skin cosmetic containing the above-described composition for skin cosmetic of the present invention is obtained. In addition, in this specification, the above-mentioned "skin cosmetic containing the composition for skin cosmetics of the present invention" may be referred to as "skin cosmetic of the present invention". The content of the skin cosmetic composition of the present invention in 100% by mass of the skin cosmetic of the present invention is not particularly limited, but is preferably 0.1 to 100% by mass, more preferably 0.5 to 10.0%. % By mass.

 本発明の皮膚化粧料用組成物(又は皮膚化粧料)の剤型としては、特に限定されないが、例えば、化粧水(ローション)、クリーム、ジェル、乳液、エアゾールスプレー、ナチュラルスプレー、スティック、パウダー、ロールオン、シート(ペーパー)などの種々の剤型が挙げられる。中でも、化粧水(ローション)、クリーム、ジェル、乳液が好ましく、化粧水(ローション)がより好ましい。  The dosage form of the composition for skin cosmetics (or skin cosmetics) of the present invention is not particularly limited, and examples thereof include lotions (creams), gels, emulsions, aerosol sprays, natural sprays, sticks, powders, and the like. Various dosage forms such as roll-on, sheet (paper) and the like can be mentioned. Among them, lotions (lotions), creams, gels and emulsions are preferable, and lotions (lotions) are more preferable.

 本発明の皮膚化粧料用組成物(又は皮膚化粧料)としては、特に限定されないが、例えば、保湿化粧料、美白化粧料、アクネケア用化粧料、アンチエイジング化粧料(例えば、しわ抑制、たるみ抑制等を目的とする)等のスキンケア化粧料;スカルプケア化粧料(例えば、保湿、皮脂抑制等を目的とする);デオドラント化粧料;日焼け止め化粧料;シェービング化粧料;ボディ用洗浄料(例えば、ボディシャンプー、固形石鹸等)頭皮用などが挙げられる。中でも、本発明の皮膚化粧料用組成物(又は皮膚化粧料)は、スキンケア化粧料、スカルプケア化粧料であることが好ましく、スキンケア化粧料であることがより好ましい。本発明の皮膚化粧料用組成物(又は皮膚化粧料)は、例えば、化粧品、医薬部外品、医薬品、雑貨のいずれであってもよい。  Examples of the skin cosmetic composition (or skin cosmetic) of the present invention are not particularly limited, and include, for example, moisturizing cosmetics, whitening cosmetics, acne care cosmetics, and anti-aging cosmetics (eg, wrinkle suppression, sagging suppression) Skin care cosmetics (for the purpose of, etc.); scalp care cosmetics (for the purpose of moisturizing, suppressing sebum, etc.); deodorant cosmetics; sunscreen cosmetics; shaving cosmetics; Body shampoo, bar soap, etc.) Among them, the skin cosmetic composition (or skin cosmetic) of the present invention is preferably a skin care cosmetic or a scalp care cosmetic, and more preferably a skin care cosmetic. The skin cosmetic composition (or skin cosmetic) of the present invention may be, for example, any of cosmetics, quasi-drugs, pharmaceuticals, and miscellaneous goods.

 本発明の皮膚化粧料用組成物(又は皮膚化粧料)を適用する部位としては、特に限定されず、顔(例えば、額、目元、目じり、頬、口元等)、腕、肘、手の甲、指先、足、膝、かかと、首、脇、背中、頭皮などが挙げられる。  The site to which the skin cosmetic composition (or skin cosmetic) of the present invention is applied is not particularly limited, and may include a face (for example, forehead, eyes, eyes, cheeks, mouth, etc.), arm, elbow, back of hand, fingertip. , Feet, knees, heels, neck, sides, back, scalp and the like.

 本発明の皮膚化粧料用組成物は、水(成分E)を媒体とする皮膚化粧料組成物において、リン脂質(成分A)、オキシエチレンの平均付加モル数が15~50のポリオキシエチレンステロールエーテル及び/又はオキシエチレンの平均付加モル数が15~50のポリオキシエチレンスタノールエーテル(成分B)、分岐鎖を有する炭素数12~24の1価の脂肪族アルコール(成分C)、プロピレングリコール、ジプロピレングリコール及び1,3-ブチレングリコールからなる群より選ばれた一種以上の多価アルコール(成分D)、ステロール(成分F)、油分(成分G)、オキシエチレンの平均付加モル数が5~30のポリオキシエチレン硬化ヒマシ油(成分H)を含む。本発明の皮膚化粧料用組成物におけるバイセル構造は、成分Aを中心として、成分B、成分C、成分F、成分G、成分Hから構成される。また成分Dは、製造時における他の成分の溶媒として機能する。上記各成分の役割は完全には解明されていないが、成分B及び成分F、成分Hが脂質二分子膜の曲率を調整し、成分Cが脂質二分子膜の柔軟性に寄与していると推定されるが、バイセル構造の安定性が特に向上する。一般的に、成分Gを配合すると、バイセル構造は不安定化する傾向にあるが、本発明においては、特に成分Hを脂質二分子膜の構成成分として含むことにより、脂質二分子膜内に成分Gを安定的に配合できることが特徴である。
 本発明の皮膚化粧料用組成物におけるバイセル構造は、ミセルとリポソームの中間の、20~50nm程度の粒径を有する。上記バイセル構造は、脂質二分子膜内に成分Gを配合できるため、ミセルよりも、より多くの成分Gを配合できる。加えて、リポソームほどの粒径を有さないため、保存安定性にも優れる。また、上記粒径の範囲であれば、透明性も損なわれることがない。
 以上のメカニズムにより、本発明の皮膚化粧料用組成物は、エモリエント効果を有する油分を含む水系の皮膚化粧料用組成物でありながら、透明性及び保存安定性に優れるものとできる。
The composition for skin cosmetics of the present invention is a skin cosmetic composition containing water (component E) as a medium, wherein the average addition mole number of phospholipid (component A) and oxyethylene is 15 to 50. Polyoxyethylene stanol ether having an average addition mole number of ether and / or oxyethylene of 15 to 50 (component B), a monovalent aliphatic alcohol having a branched chain having 12 to 24 carbon atoms (component C), propylene glycol, One or more polyhydric alcohols selected from the group consisting of dipropylene glycol and 1,3-butylene glycol (component D), sterols (component F), oils (component G), and an average number of moles of added oxyethylene of 5 to 5 Contains 30 polyoxyethylene hydrogenated castor oil (Component H). The bicellular structure in the skin cosmetic composition of the present invention is composed of component B, component C, component F, component G, and component H, with component A as the center. Component D functions as a solvent for other components during production. Although the role of each of the above components has not been completely elucidated, it is assumed that component B, component F, and component H adjust the curvature of the lipid bilayer, and component C contributes to the flexibility of the lipid bilayer. It is presumed that the stability of the bicell structure is particularly improved. In general, blending of component G tends to destabilize the bicell structure, but in the present invention, in particular, by including component H as a component of the lipid bilayer, the bicomponent structure can be contained in the lipid bilayer. The feature is that G can be stably compounded.
The bicellular structure in the skin cosmetic composition of the present invention has a particle size of about 20 to 50 nm, which is between micelles and liposomes. In the bicell structure, since the component G can be compounded in the lipid bilayer membrane, more components G can be compounded than the micelle. In addition, since it does not have the particle size of liposomes, it has excellent storage stability. Further, if the particle size is within the above range, transparency is not impaired.
By the above mechanism, the skin cosmetic composition of the present invention can be excellent in transparency and storage stability while being an aqueous skin cosmetic composition containing an oil having an emollient effect.

 以下に、実施例に基づいて本発明をより詳細に説明するが、本発明はこれらの実施例にのみ限定されるものではない。なお、表に記載の配合量は、各成分の配合量(すなわち、各原料中の有効成分の配合量。所謂純分)であり、特記しない限り「質量%」で表す。 Hereinafter, the present invention will be described in more detail with reference to Examples, but the present invention is not limited only to these Examples. In addition, the compounding amount described in the table is the compounding amount of each component (that is, the compounding amount of the active ingredient in each raw material; so-called pure content), and is represented by "% by mass" unless otherwise specified.

 実施例1~18、比較例1~11
 表に記した各成分を用い、実施例及び比較例の各皮膚化粧料用組成物を常法により調製した。
Examples 1 to 18, Comparative Examples 1 to 11
Using the components shown in the table, the compositions for skin cosmetics of Examples and Comparative Examples were prepared by a conventional method.

 表に記載の主な成分は、以下の通りである。 主 The main components described in the table are as follows.

 水添レシチン:水素添加大豆レシチン
 ポリオキシエチレンフィトスタノール:商品名「NIKKOL BPSH-25」、日光ケミカルズ株式会社製、POE-25フィトスタノール
 ポリオキシエチレンフィトステロールA:商品名「NIKKOL BPS-20」、日光ケミカルズ株式会社製、POE-20フィトステロール
 ポリオキシエチレンフィトステロールB:商品名「NIKKOL BPS-30」、日光ケミカルズ株式会社製、POE-30フィトステロール
 ポリオキシエチレンフィトステロールC:商品名「NIKKOL BPS-5」、日光ケミカルズ株式会社製、POE-5フィトステロール
 ポリオキシエチレンフィトステロールD:商品名「NIKKOL BPS-10」、日光ケミカルズ株式会社製、POE-10フィトステロール
 ステロール:フィトステロール
 ポリオキシエチレン硬化ヒマシ油A:商品名「EMALEX HC-20」、日本エマルジョン株式会社製、PEG-20水添ヒマシ油、HLB:9.0
 ポリオキシエチレン硬化ヒマシ油B:商品名「ブラウノン RCW-40」、青木油脂工業株式会社製、PEG-40水添ヒマシ油、HLB:12.5
 ポリオキシエチレン硬化ヒマシ油C:商品名「ブラウノン RCW-50」、青木油脂工業株式会社製、PEG-50水添ヒマシ油、HLB:13.5
 モノステアリン酸ポリエチレングリコール:商品名「MYS-40V」、日光ケミカルズ株式会社製、ステアリン酸PEG-40
Hydrogenated lecithin: hydrogenated soybean lecithin Polyoxyethylene phytostanol: trade name "NIKKOL BPSH-25", manufactured by Nikko Chemicals Co., Ltd., POE-25 phytostanol polyoxyethylene phytosterol A: trade name "NIKKOL BPS-20", Nikko Chemicals Co., Ltd., POE-20 phytosterol polyoxyethylene phytosterol B: trade name "NIKKOL BPS-30", Nikko Chemicals Co., Ltd., POE-30 phytosterol polyoxyethylene phytosterol C: trade name "NIKKOL BPS-5", Nikko POE-5 phytosterol polyoxyethylene phytosterol D manufactured by Chemicals Co., Ltd .: trade name "NIKKOL BPS-10", POE-10 phyto manufactured by Nikko Chemicals Co., Ltd. Sterol Sterol: Phytosterol Polyoxyethylene-hardened castor oil A: Trade name "EMALEX HC-20", manufactured by Nippon Emulsion Co., Ltd., PEG-20 hydrogenated castor oil, HLB: 9.0
Polyoxyethylene hydrogenated castor oil B: trade name "Brownon RCW-40", manufactured by Aoki Yushi Kogyo KK, PEG-40 hydrogenated castor oil, HLB: 12.5
Polyoxyethylene hydrogenated castor oil C: trade name "Brownon RCW-50", manufactured by Aoki Yushi Kogyo KK, PEG-50 hydrogenated castor oil, HLB: 13.5
Polyethylene glycol monostearate: trade name "MYS-40V", manufactured by Nikko Chemicals Co., Ltd., PEG-40 stearate

(評価)
 実施例及び比較例で得られた皮膚化粧料用組成物について以下の通り評価した。
(Evaluation)
The skin cosmetic compositions obtained in Examples and Comparative Examples were evaluated as follows.

(1)透明性
 調製直後の各実施例及び比較例の皮膚化粧料用組成物について、目視観察を行った。結果、全ての実施例は透明であった。
(1) Transparency The compositions for skin cosmetics of Examples and Comparative Examples immediately after preparation were visually observed. As a result, all the examples were transparent.

(2)保存安定性(5℃、40℃)
 各実施例及び比較例の皮膚化粧料用組成物50gをスクリュー管に入れ、5℃又は40℃の恒温機内で14日間保存した。保存後の各皮膚化粧料用組成物のスクリュー管の外観を目視で観察し、保存安定性を下記の評価基準に従って評価した。評価結果は表に記載した。
(2) Storage stability (5 ° C, 40 ° C)
50 g of the skin cosmetic composition of each Example and Comparative Example was placed in a screw tube and stored in a thermostat at 5 ° C. or 40 ° C. for 14 days. The appearance of the screw tube of each skin cosmetic composition after storage was visually observed, and storage stability was evaluated according to the following evaluation criteria. The evaluation results are shown in the table.

<保存安定性の評価基準>
 〇(良好):分離、析出物又は澱が全く認められない。
 ×(不良):分離、析出物又は澱を認める。
<Evaluation criteria for storage stability>
〇 (good): no separation, no precipitate or lees are observed.
X (poor): separation, precipitate or lees are observed.

Figure JPOXMLDOC01-appb-T000001
Figure JPOXMLDOC01-appb-T000001

Figure JPOXMLDOC01-appb-T000002
Figure JPOXMLDOC01-appb-T000002

 成分A~Hを含有し、B/A値が5.5~18.0の範囲である本発明の皮膚化粧料用組成物(実施例)は、いずれも澄明な外観を呈し、低温保存(5℃)、高温保存(40℃)の下でも、分離、析出物又は澱が全く認められなかった。すなわち、本発明の皮膚化粧料用組成物は透明性に優れ、低温及び高温での保存安定性に優れていることが分かった。 The skin cosmetic compositions (Examples) of the present invention containing components A to H and having a B / A value in the range of 5.5 to 18.0 all have a clear appearance and are stored at a low temperature ( (5 ° C.) and storage under high temperature (40 ° C.), no separation, precipitation or sediment was observed. That is, it was found that the skin cosmetic composition of the present invention was excellent in transparency and excellent in storage stability at low and high temperatures.

 一方、成分A、B、F、Hのいずれかを欠く比較例の皮膚化粧料用組成物は、低温保存(5℃)、高温保存(40℃)のいずれにおいても、分離、析出物又は澱が認められた。バイセルの二分子膜の主要構成成分である成分A、B、又はFを欠く比較例1~3では、バイセル構造自体が構成されなかったものと推測される。バイセル構造の安定化に成分H(特定のオキシエチレンの付加モル数を有するポリオキシエチレン硬化ヒマシ油)が寄与するところ、これを欠く比較例4~10はバイセル構造が安定化せず、崩壊したものと推測される。また比較例11は、B/A値が本発明に規定された範囲外であるところ、低温及び高温での保存安定性が不良となった。 On the other hand, the skin cosmetic composition of Comparative Example, which lacks any of the components A, B, F, and H, can separate, precipitate, or precipitate under any of low-temperature storage (5 ° C.) and high-temperature storage (40 ° C.). Was observed. In Comparative Examples 1 to 3, which lack the components A, B, or F, which are the main components of the bicellular bilayer membrane, it is presumed that the bicell structure itself was not formed. When component H (polyoxyethylene hydrogenated castor oil having a specific number of moles of oxyethylene added) contributes to the stabilization of the bicell structure, Comparative Examples 4 to 10 lacking this did not stabilize the bicell structure and collapsed. It is supposed to be. In Comparative Example 11, when the B / A value was outside the range specified in the present invention, the storage stability at low and high temperatures was poor.

 さらに、本発明の皮膚化粧料用組成物の処方例を示す。
〔処方例1:ローション〕
 ジプロピレングリコール                5.0質量%
 グリセリン                     15.0質量%
 トリ(カプリル酸/カプリン酸)グリセリル       3.0質量%
 スクワラン                      1.0質量%
 セタノール                      0.5質量%
 ポリソルベート60                  0.1質量%
 ポリソルベート65                  0.1質量%
 ジメチコン                      1.0質量%
 (アクリレーツ/アクリル酸アルキル(C10‐30))クロスポリマー
                            0.2質量%
 カルボマー                     0.07質量%
 1,3‐ブチレングリコール             0.08質量%
 オクトキシグリセリン                 0.2質量%
 フェノキシエタノール                 0.3質量%
 リン酸セチル                     0.1質量%
 異性化糖                       1.0質量%
 ヒアルロン酸ナトリウム               0.01質量%
 加水分解ヒアルロン酸                0.01質量%
 アルギニン                      0.4質量%
 エデト酸二ナトリウム                0.05質量%
 ビオサッカリドガム‐1               0.01質量%
 香料                        0.05質量%
 実施例3の皮膚化粧料用組成物             5.0質量%
 精製水                            残部
 合計                       100.0質量%
Further, Formulation Examples of the skin cosmetic composition of the present invention will be shown.
[Prescription example 1: lotion]
Dipropylene glycol 5.0% by mass
Glycerin 15.0% by mass
Tri (caprylic / capric acid) glyceryl 3.0% by mass
Squalane 1.0% by mass
0.5% by mass of cetanol
Polysorbate 60 0.1% by mass
Polysorbate 65 0.1% by mass
Dimethicone 1.0% by mass
(Acrylates / alkyl acrylate (C10-30)) cross polymer 0.2% by mass
0.07% by mass of carbomer
1,3-butylene glycol 0.08% by mass
Octoxyglycerin 0.2% by mass
Phenoxyethanol 0.3% by mass
Cetyl phosphate 0.1% by mass
1.0 mass% isomerized sugar
Sodium hyaluronate 0.01% by mass
Hydrolyzed hyaluronic acid 0.01% by mass
Arginine 0.4 mass%
Disodium edetate 0.05% by mass
Biosaccharide gum-1 0.01% by mass
Spice 0.05% by mass
5.0 mass% of the composition for skin cosmetics of Example 3
Purified water Remainder Total 100.0% by mass

〔処方例2:美容乳液〕
 ジプロピレングリコール                8.0質量%
 グリセリン                      2.0質量%
 イソステアリン酸プロピレングリコール         0.5質量%
 水添レシチン                     0.5質量%
 オレイン酸フィトステリル               0.1質量%
 (エチルヘキサン酸/ステアリン酸/アジピン酸)グリセリル
                            0.5質量%
 ステアリン酸グリセリル                0.3質量%
 イノシトール                     0.4質量%
 オクタステアリン酸ポリグリセリル           1.0質量%
 オクテニルコハク酸デンプンアルミニウム        0.2質量%
 ジメチコン                      1.0質量%
 ベヘニルアルコール                  1.0質量%
 ベヘン酸グリセリル                  1.0質量%
 ポリソルベート60                  0.7質量%
 コメヌカエキス                    0.1質量%
 カプリリルグリコール                 0.3質量%
 カルボマー                     0.25質量%
 オクトキシグリセリン                0.05質量%
 マカデミアナッツ脂肪酸フィトステリル         0.2質量%
 水酸化カリウム                    0.1質量%
 フェノキシエタノール                 0.1質量%
 実施例4の皮膚化粧料用組成物            10.0質量%
 精製水                            残部
 合計                       100.0質量%
[Prescription example 2: beauty milk lotion]
8.0% by mass of dipropylene glycol
Glycerin 2.0% by mass
Propylene glycol isostearate 0.5% by mass
0.5% by mass of hydrogenated lecithin
Phytosteryl oleate 0.1% by mass
(Ethylhexanoic acid / stearic acid / adipic acid) glyceryl 0.5% by mass
Glyceryl stearate 0.3% by mass
Inositol 0.4% by mass
1.0% by mass of polyglyceryl octastearate
Starch aluminum octenyl succinate 0.2% by mass
Dimethicone 1.0% by mass
Behenyl alcohol 1.0% by mass
Glyceryl behenate 1.0% by mass
Polysorbate 60 0.7% by mass
Rice bran extract 0.1% by mass
0.3% by mass of caprylyl glycol
0.25% by mass of carbomer
Octoxyglycerin 0.05% by mass
Macadamia nut fatty acid phytosteryl 0.2% by mass
Potassium hydroxide 0.1% by mass
Phenoxyethanol 0.1% by mass
Composition for skin cosmetic of Example 4 10.0% by mass
Purified water Remainder Total 100.0% by mass

〔処方例3:シートマスク〕
<化粧料組成物>
 ポリオキシエチレン硬化ヒマシ油            0.3質量%
 水酸化レシチン                    0.5質量%
 1,3‐ブチレングリコール              5.0質量%
 グリセリン                      5.0質量%
 マルチトール                     0.3質量%
 ソルビトール                     0.2質量%
 ヒドロキシエチルウレア                1.0質量%
 フェノキシエタノール                 0.3質量%
 ジプロピレングリコール                8.0質量%
 ポリエチレングリコール4000            0.4質量%
 カルボマー                     0.08質量%
 キサンタンガム                    0.1質量%
 エデト酸二ナトリウム                0.08質量%
 加水分解ヒアルロン酸                0.01質量%
 加水分解コラーゲン                 0.05質量%
 ボタンエキス                     0.3質量%
 イチジクエキス                    0.1質量%
 ローズヒップ油                   0.05質量%
 オクトキシグリセリン                0.05質量%
 水酸化カリウム                   0.08質量%
 カプリリルグリコール                0.05質量%
 ポリクオタニウム‐51               0.01質量%
 マカデミアナッツ脂肪酸フィトステリル        0.01質量%
 (メタクリル酸グリセリルアミドエチル/メタクリル酸ステアリル)コポリマー
                           0.01質量%
 実施例12の皮膚化粧料用組成物            1.0質量%
 精製水                            残部
 合計                       100.0質量%
<シート基材>
 不織布(合成繊維50%、リヨセル50%)     100.0質量%
 シート基材1.0質量部に対して、化粧料組成物を11.0質量部含浸させた。
[Prescription example 3: sheet mask]
<Cosmetic composition>
Polyoxyethylene hydrogenated castor oil 0.3% by mass
Lecithin hydroxide 0.5% by mass
1,3-butylene glycol 5.0% by mass
Glycerin 5.0% by mass
Maltitol 0.3% by mass
Sorbitol 0.2% by mass
Hydroxyethyl urea 1.0% by mass
Phenoxyethanol 0.3% by mass
8.0% by mass of dipropylene glycol
Polyethylene glycol 4000 0.4% by mass
0.08% by mass of carbomer
Xanthan gum 0.1% by mass
Disodium edetate 0.08% by mass
Hydrolyzed hyaluronic acid 0.01% by mass
Hydrolyzed collagen 0.05% by mass
Button extract 0.3% by mass
Fig extract 0.1% by mass
Rosehip oil 0.05% by mass
Octoxyglycerin 0.05% by mass
Potassium hydroxide 0.08% by mass
Caprylyl glycol 0.05 mass%
Polyquaternium-51 0.01% by mass
Macadamia nut fatty acid phytosteryl 0.01% by mass
(Glycerylamidoethyl methacrylate / stearyl methacrylate) copolymer 0.01% by mass
1.0% by mass of the skin cosmetic composition of Example 12
Purified water Remainder Total 100.0% by mass
<Sheet substrate>
Non-woven fabric (50% synthetic fiber, 50% lyocell) 100.0% by mass
11.0 parts by mass of the cosmetic composition was impregnated into 1.0 part by mass of the sheet base material.

〔処方例4:ジェルクリーム〕
 サッカロミセス/コメ発酵液             10.0質量%
 トリオクタノイン                   3.0質量%
 ジプロピレングリコール                8.0質量%
 グリセリン                      5.0質量%
 スクワラン                      5.0質量%
 ヒドロキシステアリン酸水添ヒマシ油          0.5質量%
 イソステアリン酸プロピレングリコール         0.5質量%
 水添レシチン                     0.5質量%
 オレイン酸フィトステリル               0.1質量%
 (アクリレーツ/メタクリル酸ベヘネス‐25)コポリマー0.8質量%
 ステアリン酸グリセリル                0.3質量%
 イノシトール                     0.4質量%
 オクタステアリン酸ポリグリセリル           0.3質量%
 コメヌカエキス                    0.2質量%
 ジメチコン                      1.0質量%
 ベヘニルアルコール                  1.0質量%
 ベヘン酸グリセリル                  0.3質量%
 ポリソルベート60                  0.7質量%
 コメヌカエキス                    0.1質量%
 カプリリルグリコール                0.01質量%
 カルボマー                     0.05質量%
 オクトキシグリセリン                0.05質量%
 マカデミアナッツ脂肪酸フィトステリル         0.2質量%
 水酸化カリウム                   0.15質量%
 フェノキシエタノール                 0.1質量%
 実施例13の皮膚化粧料用組成物           20.0質量%
 精製水                            残部
 合計                       100.0質量%
[Formulation Example 4: Gel Cream]
Saccharomyces / Rice fermented liquid 10.0% by mass
Trioctanoin 3.0% by mass
8.0% by mass of dipropylene glycol
Glycerin 5.0% by mass
Squalane 5.0% by mass
Hydroxystearic acid hydrogenated castor oil 0.5% by mass
Propylene glycol isostearate 0.5% by mass
0.5% by mass of hydrogenated lecithin
Phytosteryl oleate 0.1% by mass
(Acrylates / beheneth-25 methacrylate) copolymer 0.8% by mass
Glyceryl stearate 0.3% by mass
Inositol 0.4% by mass
0.3% by mass of polyglyceryl octastearate
Rice bran extract 0.2% by mass
Dimethicone 1.0% by mass
Behenyl alcohol 1.0% by mass
Glyceryl behenate 0.3% by mass
Polysorbate 60 0.7% by mass
Rice bran extract 0.1% by mass
Caprylyl glycol 0.01% by mass
Carbomer 0.05% by mass
Octoxyglycerin 0.05% by mass
Macadamia nut fatty acid phytosteryl 0.2% by mass
Potassium hydroxide 0.15% by mass
Phenoxyethanol 0.1% by mass
Skin cosmetic composition of Example 13 20.0% by mass
Purified water balance: Total 100.0% by mass

 本発明の皮膚化粧料用組成物によれば、油分を比較的多量に含むことができ、且つ透明性及び保存安定性に優れる皮膚化粧料用組成物を提供することができる。 According to the skin cosmetic composition of the present invention, it is possible to provide a skin cosmetic composition which can contain a relatively large amount of oil and is excellent in transparency and storage stability.

Claims (3)

 下記成分Aと、下記成分Bと、下記成分Cと、下記成分Dと、下記成分Eと、下記成分Fと、下記成分Gと、下記成分Hとを含有し、前記成分Aに対する前記成分Bの質量比(B/A)が5.5~18.0である皮膚化粧料用組成物。
 成分A:リン脂質
 成分B:オキシエチレンの平均付加モル数が15~50のポリオキシエチレンステロールエーテル及び/又はオキシエチレンの平均付加モル数が15~50のポリオキシエチレンスタノールエーテル
 成分C:分岐鎖を有する炭素数12~24の1価の脂肪族アルコール
 成分D:プロピレングリコール、ジプロピレングリコール及び1,3-ブチレングリコールからなる群より選ばれた一種以上の多価アルコール
 成分E:水
 成分F:ステロール
 成分G:油分
 成分H:オキシエチレンの平均付加モル数が5~30のポリオキシエチレン硬化ヒマシ油
The following component A, the following component B, the following component C, the following component D, the following component E, the following component F, the following component G, and the following component H are contained. Wherein the mass ratio (B / A) is 5.5 to 18.0.
Component A: Phospholipid Component B: Polyoxyethylene sterol ether having an average addition mole number of oxyethylene of 15 to 50 and / or polyoxyethylene stanol ether having an average addition mole number of oxyethylene of 15 to 50 Component C: Branched chain Component D: one or more polyhydric alcohols selected from the group consisting of propylene glycol, dipropylene glycol, and 1,3-butylene glycol Component E: water Component F: Sterol Component G: Oil Component H: Polyoxyethylene hydrogenated castor oil having an average added mole number of oxyethylene of 5 to 30
 さらに、下記成分Iを含有する請求項1に記載の皮膚化粧料用組成物。
 成分I:グリセリンモノ2-エチルヘキシルエーテル
The skin cosmetic composition according to claim 1, further comprising the following component I.
Component I: glycerin mono 2-ethylhexyl ether
 さらに、下記成分Jを含有する請求項1又は2に記載の皮膚化粧料用組成物。
 成分J:炭素数5~10の1,2-アルカンジオール
The skin cosmetic composition according to claim 1, further comprising the following component J.
Component J: 1,2-alkanediol having 5 to 10 carbon atoms
PCT/JP2019/036973 2018-09-28 2019-09-20 Skin cosmetic composition Ceased WO2020066895A1 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
JP2020549123A JP6982697B2 (en) 2018-09-28 2019-09-20 Composition for skin cosmetics
CN201980043706.7A CN112351768A (en) 2018-09-28 2019-09-20 Composition for skin cosmetic
KR1020207037364A KR102532929B1 (en) 2018-09-28 2019-09-20 Composition for skin cosmetics

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2018-185189 2018-09-28
JP2018185189 2018-09-28

Publications (1)

Publication Number Publication Date
WO2020066895A1 true WO2020066895A1 (en) 2020-04-02

Family

ID=69951996

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/JP2019/036973 Ceased WO2020066895A1 (en) 2018-09-28 2019-09-20 Skin cosmetic composition

Country Status (4)

Country Link
JP (1) JP6982697B2 (en)
KR (1) KR102532929B1 (en)
CN (1) CN112351768A (en)
WO (1) WO2020066895A1 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2022202880A1 (en) * 2021-03-25 2022-09-29 株式会社カネカ Lipid bilayer disc and method for producing same

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102618004B1 (en) * 2023-03-28 2023-12-27 (주)삼경코스텍 Bicelle containing natural terpene glycoside with poorly water soluble active ingredient-stabilized and method for preparing the same

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2003267830A (en) * 2002-03-15 2003-09-25 Kose Corp Liquid cosmetic
JP2012092021A (en) * 2010-10-25 2012-05-17 Fancl Corp Oil-in-water type emulsified composition
JP2014193823A (en) * 2013-03-28 2014-10-09 Kose Corp Cosmetic
WO2017090740A1 (en) * 2015-11-26 2017-06-01 株式会社コーセー Bicell structure-containing composition
JP2017178936A (en) * 2016-03-29 2017-10-05 株式会社コーセー Cosmetic
WO2018061854A1 (en) * 2016-09-28 2018-04-05 株式会社マンダム Cosmetic composition

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH05286824A (en) 1992-04-08 1993-11-02 Kanegafuchi Chem Ind Co Ltd Liposome-containing cosmetic
JPH11262653A (en) 1998-03-17 1999-09-28 Nof Corp Oil-in-water type microemulsion and cosmetic containing tide same
JP4406498B2 (en) * 2000-07-10 2010-01-27 ライオン株式会社 Skin cosmetics
AU2009323318C1 (en) * 2008-12-03 2013-08-22 Shiseido Company, Ltd. Oil-in-water cosmetic
JP2010235491A (en) * 2009-03-31 2010-10-21 Nof Corp Liposomes for cosmetics
CN103079529B (en) * 2010-10-29 2016-01-06 株式会社高丝 Vesicle composition, containing its skin preparations for extenal use and cosmetics
JP6869194B2 (en) * 2015-06-11 2021-05-12 アーチャー−ダニエルズ−ミッドランド カンパニー Lecithin compositions and methods for making and using such lecithin compositions

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2003267830A (en) * 2002-03-15 2003-09-25 Kose Corp Liquid cosmetic
JP2012092021A (en) * 2010-10-25 2012-05-17 Fancl Corp Oil-in-water type emulsified composition
JP2014193823A (en) * 2013-03-28 2014-10-09 Kose Corp Cosmetic
WO2017090740A1 (en) * 2015-11-26 2017-06-01 株式会社コーセー Bicell structure-containing composition
JP2017178936A (en) * 2016-03-29 2017-10-05 株式会社コーセー Cosmetic
WO2018061854A1 (en) * 2016-09-28 2018-04-05 株式会社マンダム Cosmetic composition

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2022202880A1 (en) * 2021-03-25 2022-09-29 株式会社カネカ Lipid bilayer disc and method for producing same

Also Published As

Publication number Publication date
CN112351768A (en) 2021-02-09
JPWO2020066895A1 (en) 2021-04-01
KR102532929B1 (en) 2023-05-16
KR20210015907A (en) 2021-02-10
JP6982697B2 (en) 2021-12-17

Similar Documents

Publication Publication Date Title
JP7020941B2 (en) Cosmetics
JP7084164B2 (en) Cosmetics containing sparingly soluble ingredients
JP2017155034A (en) Alternative oil agents for low molecular weight silicone oil
US20210220234A1 (en) Nano-Emulsion Cosmetic Composition In Which High Content Oils Are Stabilized
JP2021147342A (en) Oil-in-water type emulsion composition
JP2025124783A (en) Oil-in-water emulsion cosmetics
CN1723872B (en) Oil-in-water emulsion composition
JP5623773B2 (en) Oil-in-water emulsion composition
KR102381622B1 (en) Stabilizing method of rice bran wax and cosmetic composition containing the stabilized rice bran wax
JP6632735B2 (en) Composition for cosmetics
JP6982697B2 (en) Composition for skin cosmetics
JP7148252B2 (en) External skin preparations or cosmetics
JPWO2017179356A1 (en) Overfat and personal care compositions
JP7682661B2 (en) Oil-in-water emulsion composition
JPWO2018180316A1 (en) Emulsion cosmetic
JP6747763B2 (en) Emulsified cosmetics
JP2020164447A (en) Emulsion composition
JP2019073462A (en) Oil-in-water type emulsion skin cleanser
JP2022102419A (en) Oil-in-water drop type emulsified product
JP6674878B2 (en) Emulsified cosmetic
JP7546113B1 (en) Oil-in-water emulsion cosmetics
JP2023152863A (en) Skin cosmetic composition
JP2020147538A (en) Milky lotion-like skin cosmetic
WO2020227909A1 (en) Improved quick breaking water-in-oil emulsion
JP7309400B2 (en) emulsified cosmetic composition

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 19867642

Country of ref document: EP

Kind code of ref document: A1

ENP Entry into the national phase

Ref document number: 2020549123

Country of ref document: JP

Kind code of ref document: A

ENP Entry into the national phase

Ref document number: 20207037364

Country of ref document: KR

Kind code of ref document: A

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 19867642

Country of ref document: EP

Kind code of ref document: A1